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ABSTRACT 
Vaccination is one of the prophylactic methods to protect the animals against disease. DNA 
vaccination have shown to induce immunity against viral and bacterial pathogens in fish, 
however, the induced protection showed variable results, which demands the search for new 
approaches to improve the vaccination efficacy. The use of sorting signals associated with an 
antigen in a DNA vaccine have shown promising results in animal models, taking advantage of 
the different sorting motifs of molecules to drive the movement of the antigens inside the cell. 
Among them, sorting signals from lysosomal membrane proteins can be candidates to improve 
the efficacy of a DNA vaccine. In the present study, lysosome-associated membrane protein-1 
from Japanese flounder, Paralichthys olivaceus, (JfLAMP-1) was used as a carrier for the major 
capsid protein (MCP) from red sea bream iridovirus (RSIV) in order to evaluate its potential as 
DNA chimeric vaccine. First, JfLAMP-1 gene ORF was obtained by analyzing EST data from 
previous study in our lab and amplified by using specific primers. JfLAMP-1 amplicon was 
cloned in T vector, sequence was confirmed and bioinformatics analysis was done. Tissue 
expression analysis by RT-PCR and qPCR from gill, brain, muscle, liver, spleen, intestine, 
kidney, blood and Hirame natural embryo cell line was assessed in healthy animals. JfLAMP-
1 gene expression in spleen was assessed under poly I:C (polyinosinic:polycytidylic acid) 
stimulation at 22℃ and Edwardsiella tarda FKC (Formalin-killed cells) injection at 15 ℃ and 
22 ℃. JfLAMP-1 expression was assessed in HINAE cells by western blot and localization of 
the protein was evaluated by immunofluorescence assay. JfLAMP1 gene has a length of 1248 
bp that encodes for 415 aa (43,8 kDa) and exhibit a signal peptide, a luminal domain, 
transmembrane domain and cytoplasmic domain similar with reported in higher vertebrates. 
JfLAMP-1 gene expresses constitutively in all the tissues with a higher expression in brain. In 
E. tarda FKC injection experiment, JfLAMP-1 mRNA level showed higher at 3 h, 12 h and 7 
days post-injection at 22 ℃ and 1 day and 7 days post-injection at 15 ℃. In poly I:C stimulation, 
JfLAMP-1 showed no changes in the expression at mRNA level. In the protein analysis, 
JfLAMP-1 was detected in HINAE cells as a 56 kDa band and the immunofluorescence analysis 
showed it distributed in small and large granules in the cytoplasm and grouped close to the 
nucleus. After its characterization, JfLAMP-1 was fused with the MCP from RSIV to produce 
a chimeric DNA vaccine. For this, the DNA encoding the luminal domain of JfLAMP-1 was 
replaced with the gene for the RSIV MCP, and the construct was cloned in an expression vector 
(pCIneo). Japanese flounder juveniles (n=30) were distributed in the experimental groups 
(pCIneo, pCMCP and pCLAMP-MCP), vaccinated and the antibody titers measured 30 days 
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post-vaccination. Fish vaccinated with the chimeric vaccine pCLAMP-MCP showed 
significantly higher antibody levels than fish vaccinated with pCIneo vector harboring the MCP 
gene (p<0.05). Then a new chimeric vaccine was designed, inserting the MCP gene and keeping 
the luminal domain (LumD) of JfLAMP-1 gene. In this experiment, Japanese flounder juveniles 
(n=60) were distributed in six groups (PBS, pCIneo, pCLAMP, pCMCP, pCLAMP-MCP and 
pCLAMP-MCP-LumD). After 30 days of vaccination, fish vaccinated with the chimeric 
vaccines showed significantly higher antibody levels than those vaccinated with pCIneo vector 
harboring the MCP gene (p<0.05). The inclusion of the LumD did not induce statistically higher 
antibody titer than the pCLAMP-MCP. Then, a vaccination and challenge test were performed 
using JfLAMP-1 chimeric vaccine in a highly susceptible fish species to RSIV. For this, striped 
beakfish, Oplegnathus fasciatus, individuals were distributed in four experimental groups (PBS, 
pCIneo, pCMCP and pCLAMP-MCP; n=30 per group) and after 30 days of vaccination, a 
challenge test was done by using RSIV in low and high dose. In the vaccinated group challenged 
with low dose of RSIV, pCMCP and pCLAMP-MCP showed similar relative percentage of 
survival of 13%, however in the high dose challenge, pCLAMP-MCP vaccinated group showed 
relative percentage of survival of 19%, compared with 0% of the pCMCP. JfLAMP-1 chimeric 
vaccine induced higher protection than conventional DNA vaccine. In conclusion, chimeric 
DNA vaccines using sorting signals from specific molecules can be candidates to enhance the 
immune response against specific pathogens, for example, by modulation of the traffic of 
antigen. 
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General introduction 
 
Aquaculture is one the faster growing production system which reached 167.2 million 
tonnes in 2014, with a wide range of species and culture types, and recently there is a high 
demand for aquaculture products due to their nutritional value and variety (Figure 1)(FAO, 
2014). In addition, the fisheries and aquaculture were included in the 2030 Agenda for 
Sustainable Development in order to support a sustainable development in economic, social 
and environmental terms for the food supply of world population (FAO, 2016b). 
 
Among them, fish production plays an important role in aquaculture growth and its use 
for human consumption has outpaced population growth in the past decades, increasing at an 
average annual rate of 3.2% in the period 1961– 2013, double that of population growth, 
resulting in increasing average per capita availability (Figure 2) (FAO, 2016b) reaching above 
20 kg for 2016 (FAO, 2016a).  
 
The fish world per capita supply is almost 20 kg in average, being Asia, Europe, North 
America and Oceania, the continents with the high values of more than 20 kg, compared with 
Africa or Latin America and Caribbean. Asian countries showed the highest fish production 
with a high use of them for food supply. 
 
World food fish aquaculture production in 2014 consisted of finfish (68%), molluscs 
(22%), crustaceans (9%) and other aquatic animal species (1%). Inland aquaculture produced 
43.6 million tonnes of finfish, representing 59 % of world food fish aquaculture in 2014. 
 
 
Fish production in Asia 
 
Asia has accounted for about 89% of world aquaculture production of fish for human 
consumption in the past two decades with a total amount of 65`601.892 tonnes of aquaculture 
species, including finfish, molluscs and crustaceans (FAO, 2016b). Among Asian countries, 
China remains as the major producer although its participation in world fish production from 
aquaculture has declined slightly in the past 20 years (FAO, 2015; FAO, 2016b). Southeast 
Asia has shown the highest growth in aquaculture of the Asian sub-regions in recent years with 
a 45% increase over last decade (Ababouch & Karunasagar, 2013)  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Fish production in Japan 
 
In Japan the aquaculture and fishing industry have important roles in the diet of the 
population. Nevertheless, the consumption of seafood has decreased greatly due to changes in 
the environment surrounding food in Japan and this apparent fish consumption will remain 
static or decrease for 2025 (FAO, 2016b; Statistics Bureau, 2015). Japan's fishery output has 
been on the decline since 1989 and its 2014 fishery production totaled 4.79 million tons. Of 
this, marine fishery and aquaculture production amounted to 4.73 million tons (Statistics 
Bureau, 2015). However, among the world`s top producers and main groups of farmed species 
(Table 1), Japan ranked 11th at 1.1 million tons (1.2%), after Chile and Egypt (FAO, 2016b).  
 
Japanese aquaculture production volume accounts for 22% of the total fishery and 
aquaculture production volume in Japan (UJNR Japan Panel, 2016). Several species are 
cultured  in Japan, while the production of almost all species has decreased, especially carp 
whose production was devastated by koi herpes virus disease (UJNR Japan Panel, 2016) (Table 
2).  
 
 
Fish diseases in Japan 
 
In Japanese marine fish aquaculture, diseases, such as streptococcosis and 
pseudotuberculosis became widespread in the past, and recently several outbreaks of viral and 
bacterial diseases occurred causing economic losses (Matsuyama et al., 2016; Matsuyama et 
al., 2012; Minami et al., 2016; Yoshida, 2016; Yoshimizu, 2016). Beside to these, vaccines for 
major fish diseases have been developed with promising results (Byon et al., 2005; Byon et al., 
2006; Kato et al., 2011; Kato et al., 2012; Matsuyama et al., 2016; Shimmoto et al., 2010; 
Yasuike et al., 2007; Yasuike et al., 2011a). 
 
In order to ensure that fishery medicines do not remain in food, the pharmaceutical 
affairs act prohibits the use of medicines other than those approved by the national government 
(UJNR Japan Panel, 2016). To ensure proper use of medicines, including vaccines, a framework 
has been established whereby the prefectural fisheries experimental stations instruct methods 
of use and other necessary information on medicines to aquaculture operators. Import of foreign 
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seeds that may hold pathogens that do not exist around Japan is regulated for some fish species 
under the act on the protection of fishery resources (UJNR Japan Panel, 2016).  
 
 
Viral diseases 
 
As the other animal groups, fish are susceptible to several viral pathogens that affect a 
broad range of host (Bernoth & Crane, 1995; MacLachlan & Dubovi, 2011; Noga, 2010; 
Rexhepi et al., 2011; Smail & Munro, 2012). The epizootiology of viral infections in fish 
become complex since new susceptible species or reservoirs are discovered and also because 
the effect of the spread of virus on wild fish population are for the most part unquantified (Crane 
& Hyatt, 2011; Smail & Munro, 2012) and in some cases this spread can occurred due to 
handling practices in fisheries (Mardones et al., 2014).  
 
Although the viruses discovered/reported in fish belong to the same families than those 
reported on humans or domestic livestock, there are significant differences between the ecology 
of viral diseases of fish and those of humans or other terrestrial vertebrates (Walker & Winton, 
2010). That differences include: (1) few fish viruses are known to be vectored by arthropods, 
e.g. by parasitic crustaceans (Overstreet et al., 2009); (2) wild reservoir species are often at very 
low densities; (3) fish are poikilotherms and temperature has an exceptionally critical role in 
modulating the disease process by affecting both the replication rate of the virus as well as the 
host immune response; (4) few fish viruses are transmitted sexually between adults. However, 
as occurs for avian diseases, migratory fish can serve as carriers for long-range dispersal of 
viral pathogens (MacLachlan & Dubovi, 2011; Walker & Winton, 2010).  
 
For 2017, the OIE-Listed diseases from viral etiology for fish are: epizootic 
hematopoietic necrosis virus (EHNV), infectious hematopoietic necrosis virus (IHNV), 
infectious salmon anaemia virus (ISAV), koi herpesvirus (KHV), spring viremia of carp (SVC), 
red sea bream iridovirus (RSIV), Salmonid alphavirus (SAV) and viral haemorrhagic 
septicemia virus (VHSV), which are notifiable because represent a worldwide concern and can 
spread easily between countries with high morbidity/mortality outbreaks (OIE, 2017). Other 
viral disease enlisted in the OIE`s Manual Diagnostic test for Aquatic Animals include 
Oncorhynchus masou virus (OMV) and viral nervous necrosis virus (VNNV) (Bondad-
Reantaso et al., 2005; Crane & Hyatt, 2011; Sahoo & Goodwin, 2012; Walker & Winton, 2010). 
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In Asian countries, several viral diseases have been reported that caused important 
economic losses in fish aquaculture (Kim et al., 2011; Kim et al., 2005; Sahoo & Goodwin, 
2012; Shinmoto et al., 2009; Sohn & Park, 1998) which are demanding research in viral 
infection pathophysiology and prevention/control strategies, i.e. vaccination, genetic selection, 
among others (Costa & Thompson, 2016; Dong et al., 2013; Li et al., 2014; Lin et al., 2016; 
Ohtani et al., 2013; Robinson et al., 2017). Recently, Kim et al. (2016) and Munang’andu 
(2016) described the perspective of the use of environmental samples to study the epidemiology 
of viral diseases in aquaculture using viral metagenomics analysis which allow to understand 
the biogeographic patterns of the virus spreading and also as an overture for the design of 
rational disease control strategies. 
 
 
Fish immunity 
 
The evolution of fish and tetrapods diverged from each other about 300 million years 
ago and it is natural that fishes should be the subject of investigation of the evolution of 
lymphoid tissues and the development of the immune system (Ellis, 1998) (Figure 3). Fish have 
evolved effective immune response against infections from pathogenic agents that cohabit the 
fish`s aquatic environment and cause disease (Thompson, 2017). Since different fish species 
live in diverse environments, e.g. cold or warm water, freshwater or seawater, and so on, these 
different conditions can modulate the immune response and perturbations in the environmental 
parameters are correlated with detriment in the immunocompetence (Bowden, 2008; Makrinos 
& Bowden, 2016; Vazzana et al., 2017). 
 
Similar to mammalian immunity, fish immunity comprises two groups of immune 
responses: Innate immunity and adaptive immunity (Tizard, 2012; Uribe et al., 2011). However, 
the immune tissues/organs and some cells in fish differ from those described in mammals (Ellis, 
1998; Secombes & Ellis, 2012; Tizard, 2012) (Table 3). For example, sharks have the Leydig 
organ and epigonal organ (Mattisson et al., 1982; McClusky & Sulikowski, 2014; Rumfelt et 
al., 2002) and teleost fish possess head kidney (Abdel-Aziz et al., 2010; Kondera, 2014) (Figure 
4) which play important roles in immune cell development and differentiation. Lymphoid 
organs show different roles including to provide suitable microenvironments for the 
development of immune effector cells, mediate negative and positive selection and regulate the 
efficacy of the immune response including suppression and memory (Scapigliati, 2013). 
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Innate immune response 
 
Innate immune system is a collection of distinct subsytems that lack of any form of 
memory and work through diverse mechanisms, activated immediately when a pathogen 
penetrated the epithelial barriers such as mucus, skin or normal flora (Tizard, 2012). In fish, 
skin, gill and gut are important routes for pathogen entry because of their close contact with the 
aquatic environment (Secombes & Ellis, 2012; Thompson, 2017) and the sentinel cells as well 
as the mucosal-associated lymphoid tissue (MALT) play important roles in the surveillance and 
defense of possible infections (Parra et al., 2016; Rombout et al., 2011; Tafalla et al., 2016). 
 
Fish employ several host-derived pattern recognition receptors (PRRs) including toll-
like receptors (TLRs), similar to those found in mammals to recognize molecules commonly 
expressed on many different microbes or pathogen-associated molecular patterns (PAMPs) and 
start the immune response (Fink et al., 2016; Poynter et al., 2015; Tizard, 2012). In fish 
inflammatory responses, granulocytes arrive first and their numbers peak after 12 to 24 hours 
in order to start the secretion of antimicrobial peptides as well as enzymes and cytokines (Tizard, 
2012). In teleostean, initial inflammatory response seems to be biphasic, starting with an influx 
of neutrophils followed by later arrival of monocytes/macrophages (Reite & Evensen, 2006). 
The neutrophils move to the margin of the blood flow, getting contact with blood vessels before 
traversing the vessel walls originate from the head kidney, while macrophage appears in the 
tissues originate from blood-derived monocytes (Reite, 2005; Reite & Evensen, 2006). This is 
followed by a wave of macrophages and possibly lymphocytes (Tizard, 2012).  
 
After recognition of the pathogen and chemotaxis of the immune cells to the 
infection/injury site, the cells start to process the antigens and to synthesize acute phase proteins 
including cytokines to drive the immune response based on the characteristic of the antigen 
(Uribe et al., 2011). Several antimicrobial peptides (AMP) have been described in fish 
including hepcidins, β-defensins, piscidins, cathelicidins, histone-derived peptides (Katzenback, 
2015). The AMP are normally present in the mucus, liver and gill tissue but also can be induced 
by pathogens in the tissue (Bridle et al., 2011; Katzenback, 2015; Masso-Silva & Diamond, 
2014). For example, in Atlantic salmon (Salmo salar) after bacterial challenge with Yersinia 
ruckeri, upregulation of cathelicidin was found in the gills and spleen (Bridle et al., 2011). On 
the other hand, AMP seem to be related with several physiological processes. For example, β-
defensin was dominantly expressed in pituitary and testis of orange-spotted grouper 
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(Epinephelus coioides) and its transcript level was significantly upregulated in reproductive 
organs from intersexual gonad to testis during the natural and artificial sex reversal (Jin et al., 
2010). 
 
Intracellularly in the sentinel cells, the antigen can be processed depending of its 
intracellular or extracellular origin. Intracellular antigens such as virus, intracellular bacteria or 
intracellular protozoa are ubiquitin tagged and digested by proteasome pathway, loaded in a 
major histocompatibility complex (MHC) I molecule and located at cell membrane for 
presentation to T cells. In case of the extracellular antigens, which are engulfed and internalized 
in the cell, they are processed for the endosomal pathway which use lysosomes enzymes for the 
degradation of the antigen and its presentation by MHC II molecules for presentation to T cells. 
The cells are able to do this presentation of the antigen are called antigen presenting cells (APC) 
which are distributed throughout the organism and have some characteristics that allow the 
interaction with a T cell subpopulation (Iliev et al., 2013; Popi et al., 2016). In fish, Iliev et al. 
(2013) characterized Atlantic salmon APC based on the ability to take up soluble antigen and 
to migrate toward secondary lymphoid organ. This population was MHC II+ cells able to 
endocytose antigen. 
 
In the innate immune response, macrophages are the key cell to orchestrate the innate 
and adaptive immune response (Mills, 2015). In teleost fish, macrophages have antimicrobial 
mechanisms that include phagocytosis, secretion of AMP and chemotactic substances, 
production of reactive oxygen and nitrogen intermediates (Rieger & Barreda, 2011). Although 
there is not strong evidence of macrophage subpopulations M1 (inflammatory macrophage) and 
M2 (healing macrophage) in fish, some markers as iNOS and arginase have been proposed to 
discriminate the populations (Forlenza et al., 2011). Wiegertjes et al. (2016) described the use 
of iNOS(B), or NOS-2(B), as marker for M1 and the use of arginase-2 as marker for M2 
macrophages of teleost fish. In the same way, based on the studies on zebrafish and 
Mycobacterium murinum model, tumor necrosis factor alpha (TNF-α) was proposed as a 
putative although not unique marker for M1 macrophage in fish (Roca et al., 2008).  
 
Macrophages are able to act as APC, secrete cytokines and vasoactive molecules due to 
become an important link between innate and adaptive immune response and polarize the 
immune response even for bacterial, parasites or virus (Tizard, 2012; Verrier et al., 2011; 
Wiegertjes et al., 2016). 
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Adaptive immune response 
 
Fish adaptive immunity elicits a specific response against a pathogen; it has a memory 
component that is able to quickly eliminate pathogen upon reencountering them, which is 
similar to higher vertebrates (Thompson, 2017). A key difference between innate and adaptive 
immune systems lies in their use of cell surface receptors to recognize foreign invaders. The 
cells of innate system use a limited number of preformed receptors that bind to PAMPs. In 
contrast, the cells of the adaptive immune system generate enormous number of completely 
new, structurally unique receptors with the possibility to recognize a broad range of foreign 
molecules (Covello et al., 2013; Tizard, 2012) which are expressed on the surface of the cell as 
T-cell receptors (TCR) or B-cell receptors (BCR) or in a soluble form outside the cell (soluble 
BCR also called antibodies). Furthermore, MHC is a set of cell-surface molecules that the 
adaptive immune system uses to recognize as foreign molecules (Thompson, 2017). Although 
similar to mammalian MHC system, the mechanisms of peptide loading on the MHC molecules 
may differ in fish from those in mammals, due to the absence of some critical residues (Dijkstra 
et al., 2013; Dijkstra et al., 2007; Dijkstra et al., 2003).  
 
T- and B-cells are the main cells in the adaptive immune system and their exact timing 
of differentiation varies in different fish species, despite of the early appearance of T- and B-
cells, the full maturation is late, and the cell-mediated immunity develops earlier than the 
humoral immune response (Zapata et al., 2006).  
 
T cells can be divided in two groups depending on the TCR expressed on the surface: 
αβ and γδ (Buonocore et al., 2012; Nam et al., 2003). The majority of T-cells expressed αβ 
TCR and they can recognize peptides on the surface of APC on secondary lymphoid organs. 
On the other hand, T-cells expressing γδ TCR reside in epithelial layers of mucosal tissues 
where they work as effector cells showing cytotoxic activity but they do not recognize peptides 
processes and presented by APC (Buonocore et al., 2012; Koizumi et al., 1991). Previously, 
Nam et al. (2003) reported the four genes (α, β, γ, δ) in Japanese flounder and Lee et al. (2013) 
found their expression at mRNA level commonly expressed in the immune-related organ such 
as spleen, kidney and gill, however weak expressed in fin and eye. In adult zebrafish was 
estimated that the 2×105 T cells contain at least unique 1.5×104 TCRαβ pairs, present in low 
frequency in the zebrafish TCRαβ repertoire with bias for just some V-J combinations (Covacu 
et al., 2016). This can be related with and impaired T cell immunity as it was demonstrated in 
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murine models against virus (Yager et al., 2008). In juveniles of Dicentrarchus labrax, 
Buonocore et al., (2012) showed the upregulated expression of γTCR in the head kidney and 
down-regulated in intestine after in vivo infection with betanodavirus. 
 
In addition, two big subpopulations of T-cells have been described based on the 
expression of a cluster of differentiation (CD) on the cell surface, CD8+ and CD4+ (Tizard, 
2012). CD8+ T cells as well as NK cells, another effector cells from the same lineage, are 
effector cells than can be cytotoxic and lyse target cells by two mechanisms, namely granule 
exocytosis, in which pore-forming substance and granzymes are released, and FasL/Fas 
interaction, both of which require membrane contact with the target cell (Fischer et al., 2013). 
These pore-forming molecules as well as granzymes have been already reported in teleost 
(Athanasopoulou et al., 2009; Hwang et al., 2004; Praveen et al., 2006) 
 
CD4+ T cells are also called T helper (Th) cells and play a pivotal role in the polarization 
of the immune response to cell-mediated immunity (Th1-type response) or antibody-mediated 
immunity (Th2-type response) based on the MHC class in which the peptide antigen is loaded 
in the APC (Kono & Korenaga, 2013; Yamaguchi et al., 2015). The Th17-type of response, 
which is related with mucosal immunity and the induction of antimicrobial peptides, was also 
reported in fish (Zhang et al., 2013; Zhang et al., 2014). After antigen presentation, a specific 
types of cytokine are released which stimulate the immune response, mainly interferon (IFN)-
γ for Th1 responses, interleukin-4 for Th2 responses and interleukin-6 for Th17 responses 
(Kaiko et al., 2008; Kono & Korenaga, 2013; Korenaga et al., 2013; Tizard, 2012) (Figure 5). 
 
B-cells are able to differentiate to plasma cells which can produce antibodies (Tizard, 
2012). In mice and humans, 3 principal classes of B lymphocytes have been described on the 
basis of their ontogeny and anatomic localization: B1 and B2 B-cells, this last one which are 
divided in marginal zone (MZ) and follicular (FO) B-cells (Hoffman et al., 2016). B1 
lymphocytes express the surface markers CD5, B220lo, IgMhi, and IgDlo while B2 lymphocytes 
are CD23- and when they are located in celomic cavities, which are the major site of their 
homing and proliferation (Oliveira et al., 2005).  
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In teleost, these cells reside in the anterior and posterior kidney, spleen, gut lamina 
propia, and blood (Abelli et al., 1997; Rombout et al., 1993) and, similar to mammals, the B 
cells use the same tissue for their development as plasma cells for their residence (Fillatreau et 
al., 2013). B cells of fish retain many innate characteristics and functions and consequently are 
one of the early responders to inflammation (Castro et al., 2017). In general, in the ontogeny of 
fish B cells, Ig-producing cells appear earlier in freshwater species than marine species and they 
appear first in head kidney, followed by the spleen, and finally in the MALT and the surface 
expression of Ig occurs earlier than cytoplasmic expression (Salinas, 2015; Salinas et al., 2011; 
Zapata et al., 2006). The difference in the development of B cell in freshwater fish vs marine 
fish could be due to very distinct ecological strategies, greater egg size and earlier larvae 
development in freshwater fish (Salinas et al., 2011). 
 
In bony fish, B cell subsets can be distinguished according to their expression of distinct 
immunoglobulin (Ig) class combinations, IgM and D, or IgT only (Fillatreau et al., 2013). IgM 
constitutes the main systemic Ig and IgT plays the prevalent role in mucosal surfaces (Magadan 
et al., 2015; Mashoof & Criscitiello, 2016). However, the existence of different B cell subsets 
is still controversial, mainly because of the scarce availability of specific antibodies against 
differentially expressed markers (Castro et al., 2017), however IgM+ B cells expressing CD9 
were detected in rainbow trout which is related with “innate-like” B lymphocytes or B1 B cells 
from higher vertebrates (Castro et al., 2015). In addition, IgM+ B cells have shown phagocytic 
activity for soluble and particulate antigen, inducible expression of MHC II, and the ability to 
present antigens to T CD4+ cells (Li et al., 2006; Zhu et al., 2014) which resemble B1 B cells 
from mammals (Abos et al., 2016; Popi et al., 2016). In the same way, fish can produce natural 
antibodies at a level that is regulated in the absence of antigenic stimulation (Uribe et al., 2011) 
which support fish B cells as equivalent to B1 cells from mammals (Boes, 2000). IgM-secreting 
cells have been proved to be up-regulated in fish injected with either E. coli or VHSV when 
compared to fish injected with saline (Castro et al., 2017). 
 
 
Immunity to virus 
 
Once virus spreads beyond a few host cells a variety of non-specific and specific host 
defensive responses will be elicited (Smail & Munro, 2012). Similar to mammals, specific 
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receptors and cells are responsible to recognize and to induce the immune response against 
virus in fish (Scapigliati, 2013; Scapigliati et al., 2010; Somamoto et al., 2002). In case of 
innate immunity, TLR3 and TLR7/TLR8 are the main intracellular sensors of the foreign 
nucleic acids from virus, double-stranded RNA (dsRNA) and single-stranded RNA (ssRNA), 
respectively (Pietretti & Wiegertjes, 2014) and TLR22 which recognize dsRNA can be a cell 
surface TLR3 analog sensing the dsRNA outside the cell (Matsuo et al., 2008; Pietretti & 
Wiegertjes, 2014; Su et al., 2012). Another intracellular sensor for viral nucleic acid described 
in fish includes the proteins: nucleotide-binding oligomerization domain - NOD (NOD-like) 
(Thanasaksiri et al., 2017), melanoma differentiation-associated 5 - MDA5 (Ohtani et al., 2011) 
and the laboratory of genetics and physiology 2 - LGP2 (Chang et al., 2011; Han et al., 2016). 
 
After recognition and during the antigen processing, several cytokines are secreted in 
order to orchestrate the chemotaxis of immune cells as well as to induce a Th response 
depending on the type of antigen and the MHC restriction (Tizard, 2012). The first innate 
immune antiviral defenses are the interferon (IFN) and IFN-induced genes (ISGs) (Verrier et 
al., 2011). In fish, two subfamilies of IFN have been described: type I (α and β) and II (γ) IFN. 
However, the inflammatory functions of teleost type II IFNs have not been fully characterized, 
especially in the case of those species possessing two genes (Pereiro et al., 2016). Both types 
of IFN act as antiviral molecules and causes susceptible cells to express potent antiviral 
mechanisms to limit further viral growth and spread (Haller et al., 2006).  
 
Type I IFNs are polypeptides secreted by infected cells and induce cell-intrinsic 
antimicrobial states in infected and close cells that limit the dissemination of pathogens, 
particularly virus (Ivashkiv & Donlin, 2014). Type II IFN (known as IFN-γ) potentiates 
inflammation during viral infection, favor the expression of those genes directly related with 
the activity of macrophages and had anti-inflammatory effects during bacterial disease (Pereiro 
et al., 2016) mainly by inhibiting the production of pro-inflammatory IL-1 and IL-8, as well as 
by inducing expression of suppressors of cytokine signaling (SOCS) (Mühl & Pfeilschifter, 
2003). The IFN pathways are coordinated by intracellular signaling molecules. Most of these 
signaling molecules, including IFN regulatory factors (IRFs), Janus kinases (JAKs), signal 
transducer and activator of transcription (STAT) proteins, protein inhibitors of activated STAT 
(PIAS), and SOCS, are present in cartilaginous fish, as well as in Osteichthyes (Secombes & 
Zou, 2017).  
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After stimulation several ISGs are induced and coded for antiviral proteins such as 
double-stranded RNA- activated protein kinase (PKR), myxovirus resistance protein (Mx), the 
2`–5` oligoadenylate synthetases (2`,5`-OAS) (Qu et al., 2013). Tetrapods and fish share a 
number of ISGs that are remarkably conserved, indicating that the interferon system is an 
ancient and fundamental part of the immune system of gnathostomes (Verrier et al., 2011). In 
fish, some ISGs have been characterized which are upregulated under viral stimulation or poly 
I:C injection (Røkenes et al., 2007; Seppola et al., 2007; Yasuike et al., 2011b; Zhang et al., 
2007) and inhibit viral replication in the host (Secombes & Zou, 2017). 
 
The presentation of the antigen to the effective immune cells occurs, in order to start a 
strong and specific immune response. B cells and T cells are components of adaptive immunity, 
being responsible for antibody production and cell-mediated cytotoxicity, respectively (Fischer 
et al., 2006; Tizard, 2012). Castro et al. (2017) showed that upon intraperitoneal antigen 
stimulation (bacterial or viral), peritoneal B cell population increase which can occur due to 
increasing in the traffic from the lymphoid organs or local proliferation. Similar behavior was 
reported in the muscle after intramuscular injection of a DNA vaccine (Castro et al., 2014). On 
the other side, cytotoxic T-lymphocytes (CTL) have been described as antiviral effector cells 
in fish playing a role in the control of early viral infection (Somamoto et al., 2002) and the 
recognition of virally infected cells is MHC class I restricted (Fischer et al., 2006). The diversity 
of B cell and T cell repertoire receptor diversity is driven by the viral antigens, towards a virus 
specific response and higher clonotypic diversity, which have been shown in the DNA 
vaccination (Castro et al., 2011). 
 
 
Vaccination 
 
Vaccines are one of the prophylactic strategies used in animal production, including 
companion animals (Day et al., 2016; Day et al., 2015), to induce protective immunity against 
a corresponding infectious agent or multiple infectious agents as in the case of multivalent 
vaccines (Brun, 2016; Lee et al., 2012; Walz et al., 2015; Walz et al., 2017; Wang et al., 2012). 
However, their use and regulation are dependent on the policies of each country and based on 
the specific epidemiology of the area or zone. Previously, the world health organization (WHO) 
defined some general regulatory requirements (Shin et al., 2011). Similarly, the Pan American 
Health Organization (PANDRH, 2010) and Japan have their own regulation policies for human 
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and veterinary products, including vaccines (MAFF & NVAL, 2013; Nakayama & Aruga, 
2015). 
 
Many types of vaccines have been developed starting from live vaccines, modified-live 
vaccines, attenuated vaccines by formalin or heat, protein-based vaccines, DNA vaccines, 
among others in order to induce protection, using mainly immunodominant antigens (Nuñez-
Ortiz et al., 2016; Saul & O’Brien, 2017; Sequeira et al., 2017; Walz et al., 2017; Zheng et al., 
2016). DNA vaccines became an alternative, due to some advantages including that they are 
relatively simple to produce and safe to administer and because they are not associated with a 
viral coat, since naked nucleic acids are not generally subject to neutralizing antibody reactions 
that can hamper the clinical efficacy of vaccines based on recombinant viruses (Pereira et al., 
2014; Restifo et al., 2000; Starodubova et al., 2010). DNA vaccine plasmid contains elements 
that allow it to be amplified to large quantities in bacterial cells, and the pathogen gene is 
flanked by promoter and termination elements that facilitate its expression in eukaryotic cells 
(Kurath, 2008). However, some concerns exist about the use of “naked” plasmid DNA and the 
possibility of integration on the host genome, also known as insertional mutagenesis (Alonso 
& Leong, 2013; Starodubova et al., 2010; Tonheim et al., 2008) and unfortunately the induced 
immune response is not as strong as virus vectors or bacteria (Restifo et al., 2000). The 
mechanism of immune stimulation by nucleic acid vaccines start with the use of the host’s 
transcriptional and translational machinery to produce the antigen coded in the plasmid, i.e. 
protein, with conformation and posttranslational modification patterns identical, in most cases, 
to those which occur during normal infection (Whitton et al., 1999). This polypeptide product 
can be recognized by the immune system and its early uptake is made by myocytes which can 
present antigen to immune cells (Restifo et al., 2000) and the subsequent production of 
cytokines promotes the immune response (Løvås et al., 2014). DNA immunization induces both 
humoral and cellular immunity including both CD4+ and CD8+ T-cells, which often are 
protective against microbial challenge (Whitton et al., 1999)(Figure 6). 
 
The administration of the vaccine includes the mucosal/oral route, immersion or 
injection through the intraperitoneal (i.p.) or intramuscular (i.m.) route (Embregts & Forlenza, 
2016). In the same way, some adjuvants as well as new delivery vehicles have been reported 
(Behera & Swain, 2011; Gvili et al., 2007; Tafalla et al., 2013; Vimal et al., 2014; Zheng et al., 
2016). In addition, Kanellos et al. (1999) showed that the mode and place of injection can 
influence the distribution of the vaccine in fish tissues. Besides the i.p., i.m., immersion and 
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oral vaccination, LaPatra et al. (2015) and Salinas et al. (2015) showed the viability to use nasal 
delivery of vaccines for IHNV and enteric red mouth virus vaccines in rainbow trout, eliciting 
innate immunity and conferring early protection against experimental infection. Previously was 
demonstrated that the mucosa surfaces are important in the antigen uptake (Moore et al., 1998). 
However, this type of delivery method has not been proved in DNA vaccines. 
 
In addition, the effective concentration of plasmid for protection depends on the size of 
the fish. Previously, Corbeil et al. (2000) described that the minimal dose of DNA vaccine 
against IHNV can be as little as 1-10 ng of DNA vaccine per fish, which is enough to induce 
partial to complete protection in fry against IHNV challenge doses of 103-104 plaque forming 
units/ml. However, in large fish 10 ng of DNA vaccine per gram body weight by i.m. 
administration is required to induce protection against IHNV or VHSV in rainbow trout 
(Lorenzen et al., 2002a). 
 
 
DNA vaccines in fish 
 
Several vaccines are available in fish aquaculture, most of them targeting bacterial 
pathogens and only a few are raised against viruses (Alonso & Leong, 2013; Embregts & 
Forlenza, 2016; Park et al., 2012). For bacterial fish pathogens, killed vaccines have been 
shown good results, and the development of DNA vaccines is focused on bacteria which 
bacterins are not effective (Kurath, 2008).  
 
In fish, several studies have demonstrated the potential use of DNA vaccines, 
nevertheless, just few have been approved for commercial use (Alonso & Leong, 2013; EMA, 
2016). The fate of DNA vaccine in fish have been reviewed previously (Gillund et al., 2008; 
Seternes et al., 2007; Tonheim et al., 2008; Tonheim et al., 2008; Tonheim et al., 2007) 
however still exist the concern about consumption of DNA-vaccinated fish meat and the spills 
or waste of DNA vaccine to the environment from the production process (Tonheim et al., 
2008). In the same way, some uncertainties exist regard to whether DNA vaccines persist 
degradation in tissues, or in the environment and if the fish should be label as a genetic-modified 
organism (GMO) (Myhr, 2017). If a DNA vaccinated animal is considered to be a GMO the 
environmental legislation on the deliberate release of GMOs by producers should be 
accomplished (Hølvold et al., 2014). 
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After injection of DNA vaccine, injected plasmid can be taken up by migrating cells 
passing through the muscle or may diffuse to transfect cells at distant sites (Heppell et al., 1998). 
Thus, DNA from vaccine has been found in different cell populations as scavenger endothelial 
cells in Atlantic cod heart (Seternes et al., 2007), myocytes in rainbow trout and zebrafish 
(Boudinot et al., 1998; Castro et al., 2014; Einer-Jensen et al., 2009; Heppell et al., 1998), gills 
tissue in rainbow trout and zebrafish (Heppell et al., 1998) and Atlantic salmon kidney cells 
(Tonheim et al., 2008). On oral and i.m. vaccination experiments, DNA vaccine transcripts 
were found in gills, kidney, spleen and intestinal tissues showing the distribution of the vaccine 
through internal and external organs of vaccinated fish (Ballesteros et al., 2015; Vimal et al., 
2016). This shows that the spread of the vaccine can be wide and it can go to different tissues 
where the degradation rate can be higher (Gillund et al., 2008; Gillund et al., 2008) and it 
appeared that head kidney preferentially acts as a scavenger tissue, clearing the plasmid from 
blood circulation (Ballesteros et al., 2012). Nevertheless, the persistence time on tissues showed 
higher variability between studies (Anderson et al., 1996; Heppell et al., 1998; Salonius et al., 
2007; Vimal et al., 2016). In addition, Heppell et al. (1998) described that the expression of a 
DNA vaccine in cells other than myocytes, especially if it includes professional APC, could 
potentially contribute to improved immune responses, and could also lead to a more rapid 
decrease of the expression level of the foreign gene due to the higher turnover rate of these cells. 
 
 
Immune response of fish in antiviral DNA vaccination 
 
Same as described for higher vertebrates, DNA vaccine in fish can induce cell-mediated 
and antibody-mediated immunity (Kurath, 2008). In case of viral vaccination, the protection 
against virus-infection is non-specific during the first 18 days after injection whilst the later 
protection is virus specific and long lasting (Lorenzen et al., 2002b). Several antiviral genes 
have been showed upregulated after DNA vaccination and they can be responsible to 
orchestrate the early immune response against vaccine antigen and the subsequent antiviral state 
(Byon et al., 2005; Caipang et al., 2003; Kim et al., 2000; Robertsen, 2008) (Table 4). The 
route of administration of the vaccine showed similar gene upregulation, which was dose-
dependent (Ballesteros et al., 2015). 
 
Utke et al. (2008) showed that vaccination by using VHSV G and N protein in a DNA 
vaccine (plasmid) provoked the activation of antiviral cytotoxic cells (CTLs and NK cells). 
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Also, after DNA vaccination, T cell repertoire of anti-VHSV TCRs is large enough to allow the 
selection of diverse private responses using different VβJβ combinations in different 
individuals (Boudinot et al., 2001) which can enhance the immune response against specific 
pathogen challenge. At transcription level, DNA vaccination showed to be able to induce CD4+ 
and CD8+ gene expression upregulation which are necessary to start Th1- or Th2-type responses. 
In IHNV DNA vaccination by oral route, CD4 and CD8 gene expression was significantly 
higher than i.m. injection, and CD8 expression levels were lower than those of CD4, 
nevertheless, the i.m. injection of the vaccine did not induce significant levels of CD8 gene 
expression in kidney and spleen of vaccinated fish (Ballesteros et al., 2015). This demonstrated 
that the route of vaccine administration may influence the immune response. 
 
On the other hand, Castro et al. (2014) showed that DNA vaccination by intramuscular 
injection induced a large infiltration of both IgM+ and IgT+ cells B cells which was 
accompanied with an up-regulation of chemokines CXCL11_L1, CK5B, CK6 and CXCR3B 
genes, that possible contribute to the observed leukocyte recruitment to the muscle. Oral and 
i.m. vaccination, induced IgM and IgT gene expression as well as antibody production 
(Ballesteros et al., 2015; Vimal et al., 2016). 
 
DNA vaccination have shown to induce cross-protection in bacterial and viral 
experiments. Previously, Xu et al. (2017) showed that a DNA vaccine against a Chinese strain 
of IHNV not only provided significant protection against challenge with the parental IHNV 
strain SD-12 (genogroup J), but provided almost the same protection against intragenogroup 
challenge with other Chinese IHNV field strains. In the same way, Lorenzen et al. (2002b) 
showed that VHSV and IHNV DNA vaccines induced significant protection in rainbow trout 
against VHSV in challenge experiments performed 4 and 7 days post vaccination. In the same 
way, these two DNA vaccines induced lower protection against Y. ruckeri and A. salmonicida. 
The immune response and protection was attributed to the induction of non-specific anti-viral 
defense mechanisms which are gradually replaced by a more specific immune response. 
 
Recently, the improvement of the DNA vaccines against bacteria and virus by using 
new immunodominant antigens, adjuvants as well as delivery methods have been reported in 
fish (Chang et al., 2015; Fu et al., 2015; He et al., 2014; Liu et al., 2017). Thus, Zheng et al. 
(2016) showed that an oral DNA vaccine against turbot reddish body iridovirus (TRBIV) based 
on chitosan nanoparticles induced higher survival after challenge and higher upregulation of 
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immune-related genes, mainly TNF-α in the hindgut tissue of turbot, than the conventional 
DNA vaccine. In the same way, in Asian sea bass, Vimal et al. (2014) using chitosan–
tripolyphosphate (CS/TPP) nanoparticles as vehicles for a DNA vaccine against nodavirus 
(virus nervous necrosis virus), evidenced a higher survival rate after challenge and higher 
antibody titer at 3 weeks after vaccination compared with the conventional DNA vaccine. 
  
 
Research objective 
Vaccination is a prophylactic method that can be useful to increase the immunity against 
specific pathogens and to reduce the mortality and economic losses due to diseased animals. 
DNA vaccines have shown promising results to induce immunity against fish pathogens. 
Chimeric antigens coded in a DNA vaccine can improve the immunity against the antigens and 
the use of sorting signals in the chimeric molecule allows to drive the immune response. In this 
research, lysosome-associated membrane protein-1 (LAMP-1) from Japanese flounder was 
used as an antigen carrier in a chimeric DNA vaccine.  
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Table 1. World top producers and main groups of finfish species* 
 
Major 
producer 
Finfish 
Total aquatic 
animals 
Total 
aquaculture 
production 
Inland 
aquaculture 
Marine/coastal 
aquaculture 
China 260297.7 1189.7 45469 58795.3 
Indonesia 2857.6 782.3 4253.9 14330.9 
India 4391.1 90 4881 4884 
Vietnam 2478.5 208.5 3397.1 3411.4 
Philippines 299.3 373 788 2337.6 
Bangladesh 1733.1 93.7 1956.9 1956.9 
Rep. of Korea 17.2 83.4 480.4 1567.4 
Norway 0.1 1330.4 1332.5 1332.5 
Chile 68.7 899.4 1214.5 1227.4 
Egypt 1129.9 … 1137.1 1137.1 
Japan 33.8 238.7 657 1020.4 
Myanmar 901.9 1.8 962.2 964.3 
Thailand 401 19.6 934.8 934.8 
Brazil 474.3 … 561.8 562.5 
Malaysia 106.3 64.3 275.7 521 
World 43559.3 6302.6 73783.7 101090.7 
*Based on the data published by FAO (2016b) 
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Table 2. Production (thousands tons) by fishery type and species in Japan (2000-2014)* 
Fishery type and species 2000 2005 2010 2013 2014 
    Marine fisheries 5022 4457 4122 3734 3739 
       Tunas 286 239 208 189 187 
       Bonito 341 370 303 284 258 
       Sardine 150 28 70 218 202 
       Mackerels 346 620 492 386 502 
       Alaska Pollack 300 194 251 230 198 
       Crabs 42 34 32 30 30 
       Squids 624 330 267 228 206 
      
   Marine aquaculture 1231 1212 1111 997 987 
       Yellowtails 137 160 139 150 136 
       Oysters 221 219 200 164 184 
       Laver 392 387 329 316 267 
       Wakame seaweed 67 63 52 51 44 
       Pearl (tons) 30 29 21 20 20 
      
   Inland water fisheries 71 #54 #40 31 #31 
       Salmons and trouts 17 #19 #14 13 #11 
       Sweetfish 11 #7 #3 2 #2 
       Shellfishes 20 #14 #14 11 #12 
      
   Inland water aquaculture 61 #42 39 30 34 
       Eel 24 19 21 14 18 
       Trouts 15 12 9 8 8 
       Common carp 11 4 4 3 3 
Total 6384 5765 5313 4792 4789 
            
*Based on the data published by Statistics Bureau (2015), # Marked break in series  
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Table 3. Main differences between components of immune system from fish and mammals*  
Feature Fish Mammals 
Hematopoietic tissue Head kidney (bony fish) Bone marrow 
 Epigonal and Leydig organs (cartilaginous fish)  
   
Lymph nodes Absent Present 
   
Thymus involution Species-dependent, influence by seasonal and hormonal 
cycles 
Influence by age 
   
Gut-associated lymphoid tissue Lymphoid aggregates (not organized) Peyer patches 
   
Natural killer cells Putative NK-Like cells  
(based on single cells transcriptome analysis) 
Present 
   
Rodlet cells Present  Absent 
   
Eosinophilic granule cells Present Putative homologue (Mast 
cells or eosinophils) 
   
Germinal centers Absent Present 
   
Ig heavy chain isotypes  IgM, IgD, IgT/Z (bony fish) IgM, IgA, IgD, IgE, IgG 
 IgM, IgX/IgR, IgW, NAR(C) (cartilaginous fish)  
 IgM redox forms  
   
Ig gene rearragements Multicluster (mainly in cartilaginous fish) Translocon 
   
Non-specific diversity Several C3 isoforms No C3 isoforms 
   
Antibody affinity Low High 
   
Antibody response Slow Fast 
   
Memory response Weak Strong 
   
Affinity maturation Low or absent High 
   
 
*Based on Buchmann (2014); Carmona et al. (2017); Mashoof and Criscitiello (2016); Mazon 
et al. (2007); Moore et al. (2016); Reite and Evensen (2006); Tort et al. (2003) 
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Table 4. Genes upregulated after DNA vaccination against virus in fish  
Gene Vaccine or antigen* Reference 
Mx VHSV Acosta et al. (2005) 
 HIRV Yasuike et al. (2007) 
 IHNV Ballesteros et al. (2015); 
Verjan et al. (2008); Xu et 
al. (2017) 
 TRBIV Zheng et al. (2016) 
 SGIV Ou-yang et al. (2012) 
 RBIV-C1 Zhang et al. (2012) 
 SHRV Kim et al. (2000) 
 SVCV  
 IPNV Ballesteros et al. (2012) 
vig-1 IHNV Ballesteros et al. (2015) 
vig-2   
   
ISG15 HIRV Yasuike et al. (2007) 
 SGIV Ou-yang et al. (2012) 
ISG56 HIRV Yasuike et al. (2007) 
LB3   
Type I-IFN VHSV Acosta et al. (2006); Acosta 
et al. (2005); Chico et al. 
(2010) 
 IHNV Verjan et al. (2008) 
 TRBIV Zheng et al. (2016) 
 RBIV-C1 Zhang et al. (2012) 
 IPNV Ballesteros et al. (2012) 
IL-1β SGIV Ou-yang et al. (2012) 
 RBIV-C1 Zhang et al. (2012) 
IL-8 SGIV Ou-yang et al. (2012) 
 RBIV-C1 Zhang et al. (2012) 
 IPNV Ballesteros et al. (2012) 
TNF-α TRBIV Zheng et al. (2016) 
 SGIV Ou-yang et al. (2012) 
 RBIV-C1 Zhang et al. (2012) 
 IPNV Ballesteros et al. (2012) 
MHC (I-II) TRBIV Zheng et al. (2016) 
 SGIV Ou-yang et al. (2012) 
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 RBIV-C1 Zhang et al. (2012) 
 IPNV Ballesteros et al. (2012) 
TLR IHNV Ballesteros et al. (2015) 
CD4   
CD8   
IgM, IgT IHNV Ballesteros et al. (2015) 
 IPNV Ballesteros et al. (2012) 
*Viral hemorrhagic septicemia virus (VHSV), Hirame rhabdovirus (HIRV), Turbot reddish body iridovirus 
(TRBIV), Singapore grouper iridovirus (SGIV), infectious pancreatic necrosis virus (IPNV), Infectious 
hematopoietic necrosis virus (IHNV), rock bream iridovirus isolate 1 from China (RBIV-C1), snakehead 
rhabdovirus (SHRV), or spring viremia of carp virus (SVCV). 
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Figure 1. World capture fisheries and aquaculture production, 2009-2014. Based on FAO 
(2016b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
		
43	
 
Figure 2. World fish utilization, 2009-2014. Based on FAO (2016b) 
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Figure 3. Simplified phylogenetic tree showing the major relationships among the vertebrates 
(based on Tizard (2012)) 
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Figure 4. Lymphoid organs in bony fish (Teleostei) and cartilaginous fish (Chondrichtyes). 
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Figure 5. T-cell populations and Th responses. T-cells belong to two subpopulations: αβ and 
γδ. αβ T-cells can be subdivided in CD8+ and CD4+. CD8+ T cells can become cytotoxic 
lymphocytes (CTL) after contact with professional APC or after stimulation with IFN-γ. CD4+ 
T cells can be stimulated by APC via MHC-TCR interaction which induces a specific profile 
of cytokines that starts Th immune responses (Th1, Th2, Th17) based on the origin of the 
antigen intracellular or intracellular. The Th response depends on the cytokine secreted, and 
this induced inhibitory signal on the other, e.g. IFN-γ in the Th1 response inhibits the secretion 
of IL-4 which decrease the Th2 response and viceversa. 
 
 
CD8+
CD4+
T cell
CTL
Th1
Th2
Th17
(Th0)
IFN-γ
IL-2 
TNF-β 
IL-4
IL-5
IL-10
IL-13
IL-6
IL-21
TGF-β
APC
TCR
MHCAPC
TCR
MHC
αβγδ
		
47	
 
Figure 6. Schematic explanation of DNA vaccination. A gene coding for a specific antigenic 
protein from a pathogen is isolated and cloned in the vaccine plasmid, which is transformed in 
a competent cell (e.g. bacteria, yeast), produced at large scale and purified. After purification, 
the vaccine is administered and the muscle cells endocytose the plasmid and synthesize the 
antigenic protein. The antigenic protein is released into the extracellular space as well as 
presented on the cell surface, where local antigen-presenting cells initiate the immune response. 
The secretion of cytokines helps in the recruitment of immune cells and the early local 
inflammatory response. Antigenic peptides can be presented to T cells by MHCI or MHCII 
which can stimulate Th1 or Th2 immune responses, respectively, and specific cytokines in each 
response are secreted. Th1 responses are characterized for the stimulation of CD8+ T cells while 
Th2 response is for CD4+ T cells. Th1 immune response generates a cytotoxic response by 
CD8+ activated T cells and Th2 immune response generates and antibody production by 
activated B cells (plasma cells). In both responses, memory cells are generated. 
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Characterization of lysosome-associated membrane protein-1 
(LAMP-1) in Japanese flounder (Paralichthys olivaceus) 
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Abstract 
Lysosomes play an important role in cellular metabolism and several lysosomal proteins are 
pivotal for physiological processes including cell-to-cell interactions, embryonic development, 
antigen presentation and autophagy. Lysosome associated membrane protein-1 (LAMP-1) is 
one the main lysosomal membrane proteins that interact in immune responses and mediates the 
antigen processing inside the cell. In the Japanese flounder, Paralichthys olivaceus, the 
lysosomal protein has not bet yet characterized. The present study aimed to characterize the 
LAMP-1 gene in Japanese flounder through tissue distribution and expression analysis. 
Japanese flounder LAMP-1 (JfLAMP-1) gene ORF was obtained by analyzing EST data from 
previous study in our lab, amplified and cloned by using specific primers. Tissue expression of 
JfLAMP-1 gene was assessed from several tissues in healthy animals and in spleen under 
Edwardsiella tarda FKC (Formalin-killed cells) and poly I:C injection. JfLAMP-1 expression 
was assessed in HINAE cells by western blot and localization of the protein was evaluated by 
immunofluorescence. JfLAMP-1 gene has a length of 1248 bp that encodes for 415 aa (43,8 
kDa) and exhibit a signal peptide and 3 conserved domains (luminal domain, transmembrane 
domain and cytoplasmic domain) similar with reported in higher vertebrates. JfLAMP-1 gene 
expresses constitutively in all the tissues examined. At E. tarda FKC injection JfLAMP-1 
expression can be upregulated at 3 h, 12 h and 3 days for 22 ℃ and 1 day and 7 days for 15 ℃. 
No changes in mRNA level of JfLAMP-1 were detected on poly I:C injected animals. JfLAMP-
1 was detected in HINAE cells as a 56 kDa band and the immunofluorescence analysis showed 
it distributed in small and large granules in the cytoplasm and grouped close to the nucleus. The 
characterization of lysosomal proteins in fish increase the basic biology knowledge to 
understand the immune response as well as open possibilities for new cell marker in cell 
development or the use of lysosomal proteins in immunization strategies. 
 
Keywords: Lysosome, Japanese flounder, gene expression, tissue distribution  
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1. Introduction 
 
Lysosomes are found in all eukaryotic cell types and participate with the endocytic pathway 
(Johnson et al., 2016; Luzio et al., 2014). They are characterized by a highly acidic lumen, rich 
in hydrolytic enzymes and responsible for degradation of macromolecules from the 
extracellular environment (Sun-Wada et al., 2003) as well as interaction with major 
histocompatibility complex (MHC) class II molecules (Villadangos, 2001; Watts, 2012). 
Lysosomes generate and maintain an acidic lumen by means of the vacuolar H+-ATPase and 
their position in the cells as well as their pH can be related with heterogeneous function in the 
cell (Johnson et al., 2016; Lübke et al., 2009).  
 
In general, lysosomes constitute up to 5% of the intracellular volume of animal cells 
(Luzio et al., 2014) and their morphology and level differ between tissues and cell types which 
allows to have several roles in physiology (Klumperman & Raposo, 2014; Sun-Wada et al., 
2003). For example, in cytotoxic T lymphocytes (CTL) and a small number of other cell types, 
lysosomes are also secretory organelles called as lytic granules that contain specialized 
secretory proteins in addition to lysosomal hydrolases (Page et al., 1998). Approximately 13 
lysosome-related organelles (LRO) have been described in different cell types and include 
melanosomes, platelet dense granules, Weibel-Palade bodies and neutrophil azurophil granules 
(Bonifacino, 2004; Jani et al., 2016; Luzio et al., 2014) and the congenital deficiency of 
lysosomes or LRO or some lysosomal proteins have been associated with several diseases and 
syndromes (Callahan et al., 2009; Jani et al., 2016) 
 
Lysosomal membrane proteins are highly glycosylated (Fukuda, 1991; Hatakeyama et 
al., 2014) and it was estimated that lysosome associated membrane proteins (LAMPs) and 
lysosome integrated membrane proteins (LIMP) constitute about 50% of all proteins in 
lysosomal membrane (Hunziker et al., 1996; Marsh et al., 1987) and some of them can be 
expressed on the cell surface (Furuta et al., 1999; Hatakeyama et al., 2014; Tompkins et al., 
2006). LAMP-1 and LAMP-2 are physiologically essentials and the deficiency of them in mice 
are embryonic lethal, with the accumulation of autophagic bodies in several tissues (Eskelinen 
et al., 2004; Terasawa et al., 2016). Furthermore, late endosomes/lysosomes as well as 
phagosomes lacking LAMP-1 and LAMP-2 had reduced ability to move toward the 
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microtubule-organizing center, likely precluding their interaction with each other (Huynh et al., 
2007). 
 
LAMPs are type I transmembrane proteins with a large luminal domain, one 
transmembrane domain and a C-terminal cytoplasmic tail (Eskelinen, 2006). Luminal domain 
is glycosylated with some O-glycans and a large number of N-glycans, most of which are of 
the complex poly-N- acetyllactosamine type, thus explaining the low pI between 2 – 4 exhibited 
by the proteins (Eskelinen et al., 2003). In addition, the short terminal cytoplasmic tail, 
corresponding to 10-11 amino acids, determines the sorting of LAMPs (Dahlgren et al., 1995) 
and their tissue distribution (Furuta et al., 1999).  
 
Besides of its function as interacting molecules, LAMP-1 showed to protect natural 
killer cells from the degranulation-associated damage (Cohnen et al., 2013) and it is highly 
expressed in some tumors with a possible role in cell-to-cell adhesion and migration (Jensen et 
al., 2013). Recently, it was used to the design of vaccines against some diseases (Arruda et al., 
2006; Dhalia et al., 2009; Nawaratna et al., 2015). In Japanese flounder (Paralichthys 
olivaceus), LAMP molecules are not yet characterized. The aim of this study is to characterize 
the Japanese flounder LAMP-1 (JfLAMP-1) gene through tissue distribution and expression 
analysis.  
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2. Material and methods 
 
2.1. JfLAMP-1 Cloning 
Based on EST analyses of Japanese flounder transcripts (Kondo et al., 2014), primers were 
designed to amplify the open reading frame (ORF) of Japanese flounder LAMP-1 (JfLAMP-1) 
(Table 1), including restriction enzymes sites for NdeI and EcoRI and cDNA from spleen was 
used as a template. PCR products were ligated and cloned into pGEM T-easy vector (Promega, 
USA) and sequenced using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied 
Biosystems, USA) with a 3130xl genetic analyzer (Applied Biosystems). Putative signal 
peptide was predicted using SignalP (http://www.cbs.dtu.dk./services/SignalP/) and 
InterproScan was used to predict the domains (luminal, transmembrane and cytoplasmic) 
(http://www.ebi.ac.uk/interpro/). NetNGlyc and NetOGlyc programs were used for prediction 
of N-linked and O-linked glycosylation sites (http://www.cbs.dtu.dk./services/NetNGlyc/, 
http://www.cbs.dtu.dk./services/NetOGlyc/). Multiple sequence alignments were generated 
using GENETYX-MAC 16.0.7 software (Software Development Co., Ltd., Tokyo, Japan) and 
Geneious® 8.1.7 (Biomatters Limited) (Kearse et al., 2012), and identity values were calculated 
using SIAS tool (http://imed.med.ucm.es/Tools/sias.html). 
 
2.2. Tissue expression 
For JfLAMP-1 mRNA expression analysis, total RNA was extracted from healthy Japanese 
flounder (n=3) using RNAiso plus reagent and RNAiso blood reagent (Takara Bio. Inc., Otsu, 
Japan) from several tissues including gill, brain, muscle, liver, spleen, intestine, kidney and 
blood. In the same way, total RNA was extracted from HINAE (hirame natural embryo) cell 
line (Kasai & Yoshimizu, 2001), which was maintained in Leibovitz's L-15 (Life Technologies, 
Carlsbad, CA, USA) medium containing 10% FBS (Life Technologies), 100 units/ml of 
penicillin, 100 µg/ml of streptomycin 25 °C. cDNA was synthesized using SuperScript™ III 
First Strand synthesis system M-MLV (Life Technologies). 
 
2.2.1. RT-PCR and qPCR (quantitative real-time PCR) 
RT-PCR was performed with cDNA templates (5 times diluted) from each tissue using 
specific primer sets for JfLAMP-1 (Table 1) under the following PCR conditions: initial 
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denaturation at 95 °C for 4 min, followed by 25 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C 
for 1 min and a final extension of 72 °C for 7 min. EF-1α gene was used as an internal control. 
The PCR products were electrophoresed on 1% agarose gels.  
 
For qPCR, specific primer sets (Table 1) were designed and the reaction was carried out 
using SYBR green PCR master mix (Applied Biosystems) on a StepOnePlus Real-time PCR 
system (Applied Biosystems) according to the manufacturer's protocol. EF-1α was used as a 
housekeeping gene for internal control. The expression levels of JfLAMP-1 gene were 
normalized to the expression level of the housekeeping gene, calculated using the 2∆∆Ct method 
(Livak & Schmittgen, 2001), and were expressed as fold change relative to blood (set as 1). 
 
2.2.2. JfLAMP-1 expression in Edwardsiella tarda FKC-injection model 
Juveniles of Japanese flounder (average weight of 4.2 g) were distributed 200-l tanks 
supplying filtered seawater at 15°C and 22°C. Fish were injected i.p. with a dose of 2.3 x 108 
cfu/fish of FKC Edwardsiella tarda. Spleen was sampled at different sampling times (5 fish per 
group/sampling time): 0 h (before injection), 3 h, 6 h, 12 h, day 1, day 2, day 7 and day 14 post 
injection. RNA extraction as well as cDNA synthesis were done as describe above. Primers sets 
used for the analysis are enlisted in Table 1. 
 
2.2.3. JfLAMP-1 expression in polyinosinic-polycytidylic acid (poly I:C) stimulation 
Japanese flounder (average weight of 15 g) individuals were distributed 200-l tanks 
supplying filtered seawater at 22°C. Fish were injected intraperitoneally with a dose of 100 µg 
of poly I:C/fish. Spleen was sampled from experimental animals at different sampling times (5 
fish/sampling time): 0 h (before injection), 3 h, 6 h, 12 h, day 1, day 2, day 7 and day 14 post 
injection. RNA extraction and cDNA synthesis was made as describe above. JfLAMP-1 
expression was assessed by qPCR analysis and EF-1α was used as a housekeeping gene for the 
normalization of the data. Primers used for the analysis are enlisted in Table 1. 
 
2.2.4. Expression of JfLAMP-1 in HINAE cells 
Expression of JfLAMP-1 in HINAE cells was assessed by western blot and 
immunofluorescence using rabbit anti-JfLAMP -1 as a primary antibody (1:1000). Antiserum 
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was developed by immunizing rabbit with a JfLAMP-1 synthetic peptide sequence, NH2-
C+GRKRSHAGYQTI-COOH (Eurofinsgenomics Co Ltd, Japan) and its specificity was 
confirmed by using the recombinant JfLAMP-1 (rJfLAMP-1) in a western blot analysis. 
rJfLAMP-1 was produced using pET-32a expression vector and transformed in Escherichia 
coli BL21(D3) strain.  
 
For western blotting, cultured HINAE cells after confluent stage were removed from 
culture flask by trypsin digestion and washed three times with phosphate buffer saline (PBS). 
Cell pellet was suspended in PBS, mixed with 2x SDS sample buffer (ratio 1:1) and analyzed 
by sodium dodecyl sulphate-polyacrylamide electrophoresis (SDS-PAGE) (12%) and western 
blot. Anti-Rabbit IgG (Fc) AP conjugate (Promega, USA) was used as secondary antibody 
(1:3000). For immunofluorescence detection, HINAE cells were cultured in 6-well plates with 
a coverslip in the bottom. Cells were washed in PBS by triplicate and fixed in the coverslip. 
Primary antibody diluted in PBS-T (PBS + Tween 20) was added to each well and incubated 
for 1 h. Then, the cells were washed thrice with PBS-T and the secondary antibody (Goat Anti-
Rabbit IgG FITC; Cayman chemical, USA) was added and incubated in dark condition for 1 h. 
Cells were washed three times and then their nucleus were stained using Hoechst (Invitrogen, 
USA) and observed under fluorescence microscope (Nikon Eclipse Ci, camera DS-Ri1; Nikon, 
Japan). Images were analyzed using Fiji (ImageJ) software (Schindelin et al., 2012).  
 
2.4. Statistical analysis 
Differences in gene expression were evaluated with a t-test. Statistical analyses were done 
with GraphPad Prism v 6.0 (La Jolla, CA, USA). Differences were considered statistically 
significant when p < 0.05.  
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3. Results 
 
3.1. cDNA cloning and characterization of JfLAMP-1 
The ORF for JfLAMP-1 (accession number: LC127058) has a length of 1248 bp that 
encodes for 415 aa (43,8 kDa). The 3’UTR had a polyadenylation signal (AATAA) 854 bp 
downstream of the translation termination codon (TGA)(Figure 1). JfLAMP-1 contains the 
signal peptide and 3 domains: luminal domain, transmembrane domain and cytoplasmic domain. 
In the same way, 9 predicted N-glycosylation sites and 14 predicted O-glycosylation sites were 
detected (Figure 1). Eight conserved cysteine residues are present in the predicted protein, 
which have been reported to form 4 disulphide bridges (Carlsson & Fukuda, 1989). Luminal 
domain showed a high O-glycosylation region (hinge region) which is rich in threonine and 
proline and divide the luminal in two fragments or loops (Figure 2). The HAGYQTI motif, 
which is responsible for the sorting of molecule inside the cell (Braulke & Bonifacino, 2009), 
was in the position 409-415 and it is the most conserved region between LAMP-1s. 
Transmembrane domain also showed high identity between LAMP-1 molecules (Figure 3). The 
LAMP-1 amino acid sequences showed a pairwise identity of 51.8% among the species 
analyzed. 
 
Phylogenetic analysis based on the amino acid sequences of LAMP from vertebrates 
showed that several fish species were grouped in the same cluster and LAMP-1 from Fugu, 
Asian sea bass, Bicolor damselfish and Black rockcod were the closest to JfLAMP-1 (Figure 
4). On the other hand, identity index showed values in a range from 39% to 92% among the 
species (Table 2) 
 
3.2. Tissue expression of JfLAMP-1 
JfLAMP-1 mRNA was detected in blood, gills, brain, muscle, liver, spleen, intestine, 
kidney and HINAE cells as a constitutive gene (Figure 5a & 9a). However, in liver the mRNA 
levels were slightly lower compared with the others. Relative gene expression of JfLAMP-1 by 
qPCR showed the brain with high values (Figure 5b). 
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In E. tarda FKC-injected fish, the JfLAMP-1 gene expression in spleen was significantly 
upregulated at 3h, 12h (p<0.05) and 3 days (p<0.01) after injection at 22℃ (Figure 6) and at 1 
day and 7 days post-injection at 15℃ (Figure 7). However, in poly I:C stimulation, there were 
no changes in the JfLAMP-1 gene expression at any time assessed (Figure 8). 
 
Protein expression analysis of JfLAMP-1 by western blot showed a band of ~56 kDa 
(Figure 9c). The specificity of the primary antiserum used for the protein analysis was 
confirmed in the rJfLAMP-1 which appeared as a band of ~44 kDa (Figure 9b). In the 
immunofluorescence analysis in HINAE cells, the expression of JfLAMP-1 showed with a 
throughout distribution in the small and large granules in the cytoplasm and grouped close to 
the nucleus (Figure 10).  
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4. Discussion 
 
4.1. JfLAMP-1 characterization 
This is the first characterization of LAMP-1 in fish, however, LAMP-3 was reported 
previously (Johansson et al., 2012), which showed similarities in the sorting motif. Human 
LAMP genes are present in different chromosomes suggesting that they diverged early in 
evolution of vertebrates and have distinct functions (Furuta et al., 1999). In the present study, 
JfLAMP-1 showed molecular mass and conserved domains similar to LAMP-1 in higher 
vertebrates (Carlsson et al., 1988; Chen et al., 1988; Fambrough et al., 1988; Fukuda et al., 
1988; Mane et al., 1989). Transmembrane and cytoplasmic domains of JfLAMP-1 showed high 
identity and the YXXØ- sorting signal specifically the motif –HAGYQTI was highly conserved. 
YXXØ motifs are essential for the intracellular targeting after biosynthesis including rapid 
internalization of LAMP-1 from the plasma membrane, interaction with transmembrane 
proteins as well as with trans-Golgi network and endosomes (Bonifacino & Traub, 2003; 
Fukuda, 1991; Hunziker & Geuze, 1996; Hunziker et al., 1996). 
 
JfLAMP-1 showed many potential N- and O- glycosylation sites as reported previously in 
humans (Carlsson et al., 1988; Mane et al., 1989), which can increase the size of the molecule 
and this glycosyl moiety can constitutes about 60% of the total mass (Eskelinen et al., 2003). 
N-glycosylation seems to be important for the stability of the proteins in the lysosomal 
membrane (Barriocanal et al., 1986; Kundra & Kornfeld, 1999) and as candidate to receptor 
site for binding microbial lectins (Carlsson & Fukuda, 1989; Dahlgren et al., 1995). Opposite 
to human LAMP-1 (Fukuda et al., 1988), the N-glycosylation sites in JfLAMP-1 are far from 
the transmembrane domain. The proximity of N-glycosylation sites to the transmembrane 
domain has been described as pivotal for formation of polylactosaminoglycans (Fukuda, et al., 
1988) and the reduction in these polylactosaminoglycans are correlated with the cell 
differentiation of colonic human adenocarcinoma (Brockhausen et al., 1991; Youakim et al., 
1989). On the other hand, JfLAMP-1 O-linked glycosylations are distributed in clusters at the 
hinge region which is rich in proline and threonine, similar to described in another species 
(Carlsson et al., 1988; Chen et al., 1988; Fambrough et al., 1988; Mane et al., 1989) and divide 
the luminal domain in two segments and together with the cysteine residues and disulphide 
bonds can induce an immunoglobulin-like loop (Carlsson & Fukuda, 1989). These O-linked 
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glycosylations likely protect this region from intraluminal lysosomal proteases (Carlsson et al., 
1993).  
 
4.2. Expression of JfLAMP-1 in tissues 
The expression of JfLAMP-1 mRNA was detected in all the examined tissues as a 
constitutive gene, similar to the expression of another genes of the LAMP family (Johansson et 
al., 2012). In human, Furuta et al., (1999) assessed the expression of LAMP-1 in different 
tissues (cerebral cortex, colonic mucosa, kidney cortex, liver, lung, pancreas, prostate, spleen, 
and uterine myometrium) by immunohistochemistry and Northern analysis showing 
constitutive expression in all of them. However, the expression of LAMP-1 in brain neurons 
was virtually absent. In case of JfLAMP-1, quantitative expression analysis showed higher 
relative values in brain tissue. On the other hand, JfLAMP-1 was highly expressed in HINAE 
cells which is similar to F9 embryonal carcinoma cells where the LAMP-1 is high and can be 
modulated by retinoic acid in a time- and dose-dependent manner (Amos & Lotan, 1990). This 
high expression of LAMP-1 as well as its glycosylation state in embryonic stages is associated 
with early stages of cell differentiation in which LAMP-1 can modulate the process together 
with another molecule (Amos & Lotan, 1990; Brockhausen et al., 1991; Romero et al., 1993; 
Youakim et al., 1989). Expression of LAMP-1 can differ between cell populations or cellular 
compartments (e.g. granules) (Dahlgren et al., 1995) and the variation in the expression of 
LAMP-1 in fish cells can be related with cell differentiation and investigated in the future as a 
cell development marker. 
 
The western blot analysis of JfLAMP-1 in HINAE cells showed a band of approximately 
56 kDa, which was also present in other tissues examined previously. Although the predicted 
size of JfLAMP-1 is 43.8 kDa, N- and O-glycosylations of the molecule may increase its weight 
as demonstrated in other species, where LAMP-1 can also appear as a “smear” band of broad 
range size (e.g. 90-120 kDa) (Amos & Lotan, 1990; Carlsson et al., 1988; Eskelinen et al., 
2003; Mane et al., 1989; Zhou et al., 1993). The size of the rLAMP-1 was detected as a band 
of 44 kDa which support the assumption of change of the protein mass due to the glycosyl 
moiety, due to the lack of post-translational modifications in recombinant protein produced in 
prokaryotic host (Sahdev et al., 2008). 
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By immunofluorescence analysis, JfLAMP-1 appeared distributed in cytoplasmic granules 
with different intensity and frequently grouped in the perinuclear area. These findings of the 
distribution are similar to the results reported in embryonic (Fehrenbacher et al., 2008) and 
differentiated cells (Dahlgren et al., 1995; Jensen et al., 2013; Parkinson-Lawrence et al., 2005; 
Sadaka et al., 2009; Sarafian et al., 2006; Zhou et al., 1993). 
 
Previous studies have reported that FKC-injected Japanese flounder showed upregulation 
of immune-related genes (Dumrongphol et al., 2009; Kondo et al., 2014; Lyu et al., 2016). 
Kondo et al. (2014) previously reported that E. tarda FKC-immunization differentially 
upregulates clusters of immune-related genes mainly those related with cellular and metabolic 
process. In this study, JfLAMP-1 expression in E. tarda FKC-injected Japanese flounder was 
assessed by real-time PCR showing an upregulation at 3h, 12h and 3 days post-injection. 
However, there is not any reports of the evaluation of gene expression of LAMP-1 in fish or 
neither in FKC nor bacterial challenge model. Nevertheless, in case of rainbow trout LAMP-3 
gene in vivo and in vitro studies were done (Johansson et al., 2012). In vivo challenge with 
Yersinia ruckeri increased the expression of LAMP-3 in gills and head kidney 24 h after i.p. 
challenge and after 48 h the level expression return to basal. On the other hand, in vitro study 
showed that following Poly I:C and E. coli lipopolysaccharide stimulation of mononuclear cell 
line an upregulation of its expression was observed at 8 h post-stimulation which return to basal 
levels at 24 h. In our study the upregulation was observed at 3 h post-injection which is 
agreement with the observation of Huynh et al. (2007) who demonstrated that the displacement 
for phagolysosome fusion was evidenced at 3 h in fibroblast and the role of LAMP-1 in the late 
endosome interaction (mediated by Rab7).  
 
Poly I:C is a synthetic dsRNA compound that mimic the effect of viral dsRNA antigen and 
have been used to detect antiviral response in fish (Røkenes et al., 2007; Seppola et al., 2007; 
Yasuike et al., 2011). In the present study, the stimulation with poly I:C did not induce changes 
in the gene expression of JfLAMP-1 which is supported in studies by Watanabe et al. (2011) 
who showed that poly I:C was uptaked by receptor on the plasma membrane and moved to the 
TLR3-positive early endosomes, but did not colocalize with LAMP-1, demonstrating that 
LAMP-1 may not participate in the processing pathway. In contrast, Zou et al. (2013) 
demonstrated that poly I:C was colocalized with LAMP-1 in dendritic cells at 2 h after 
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stimulation but this colocalization disappear at 12h. 
 
In conclusion, JfLAMP-1 gene was characterized and its tissue expression under normal 
condition as well as E. tarda FKC and poly I:C stimulation, which showed that JfLAMP-1 is a 
constitutive gene and can participate in the immune response against bacteria. 
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Table 1. PCR primers used in this study. 
Target Usage Primer sequence (5′–3′)* 
JfLAMP ORF Cloning F AACATATGGAACTCTCTCACACGGT 
 Cloning R GAATTCGATGGTCTGGTATCC 
JfLAMP-1 RT PCR GCGGCCGCATGGAACTCTCTC 
 RT PCR GGCTTCACATAATCCAGACACATTT 
 qPCR F GTTCAACATCTCCTACGTCTCAAAA 
 qPCR R GGCTTCACATAATCCAGACACATTT 
EF1α RT PCR/qPCR F CTCGGGCATAGACTCGTGGT 
 RT PCR/qPCR R CATGGTCGTGACCTTCGCTC 
*Restriction enzyme sites (NdeI and EcoRI) are underlined at the start of the sequence. 
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Table 2. Amino acid identity index (%) in LAMP-1 from different species compared with the 
JfLAMP-1*. 
 
 
*Genbank accession numbers or Ensembl protein ID: Japanese flounder LAMP-1 (LC127058), 
Fugu uncharacterized protein (H2V4H1), Zebrafish LAMP-1 (Q6P299), Japanese medaka 
uncharacterized protein (H2LIM4), Nile tilapia (I3J577), Amazon molly LAMP-1 
(XP_007554035.1), Three-spined stickleback uncharacterized protein (G3PRL1), Channel 
catfish LAMP-1 (W5UCE1), Salmon LAMP-1 (C0H980), Asian sea bass predicted LAMP-1 
(XP_018539319.1), Bicolor damselfish predicted LAMP-1 (XP_008273729.1), Black rockcod 
predicted LAMP-1 (XP_010784816.1), Southern platyfish uncharacterized protein (M4AXY6), 
Australian ghostshark LAMP-1 (V9KCK3), Mouse LAMP-1 (Q9DC13), Human LAMP-1 
(NP_005552.3). 
  
  2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 Japanese flounder 83.61 77.59 65.54 75.9 71.32 63.65 68.68 70.84 65.06 65.3 53.64 48.66 42.4 39.8 39.03 
2 Asian seabass  81.68 70.02 78.41 74.58 67.07 73.3 75.53 68.58 66.66 55.58 51.09 42.92 40.29 40.76 
3 Bicolor damselfish   66.5 77.83 72.53 67.07 69.41 71.8 66.74 63.61 52.66 49.14 42.65 39.06 40 
4 Three-spined stickleback    69.04 63.3 56.58 61.16 62.67 57.41 57.99 46.84 47.93 37.61 36.85 36.69 
5 Black rockcod     72.42 66.58 67.71 69.85 63.15 62.05 54.61 49.39 42.38 39.55 40.28 
6 Fugu      64.63 68.93 68.82 63.54 61.87 52.18 47.93 44.6 37.59 38.12 
7 Nile tilapia       59.75 61.95 61.46 57.07 48.04 45.6 42.92 39.06 38.04 
8 Amazon molly        92.71 66.99 62.13 52.18 49.87 40.29 37.1 37.62 
9 Southern platyfish         67.7 61.48 52.42 50.12 41.14 38.32 38.36 
10 Japanese medaka          59.8 49.75 46.71 44.01 38.82 38.84 
11 Salmon           52.18 50.85 41.28 38.08 37.41 
12 Channel catfish            49.63 39.56 39.06 37.86 
13 Zebrafish             40.38 37.34 37.71 
14 Australian ghostshark              41.27 41.24 
15 Mouse               66.09 
16 Human                
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Figure 1. Japanese flounder LAMP-1 nucleotide/amino acid sequence analysis. N-linked 
glycosylation sites are continuous underlined and O-linked glycosylation sites are marked by 
asterisks. Conserved cysteine residues are boxed.  
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Figure 2. Schematic model of Japanese flounder LAMP-1 peptide (without the signal peptide). 
Conserved Cysteine residues (green), N-glycosylation (blue), O-glycosylation sites (red), 
Cytoplasmic domain (underlined). Disulphide bonds appear between conserved cysteine 
residues. Model was build based on the human LAMP-1 structure described in Carlsson and 
Fukuda (1989). 
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Figure 3. Multiple sequence alignment of LAMP-1 amino acid sequence. The amino acid 
sequences were obtained from Genbank accession numbers or Ensembl protein ID: Japanese 
flounder LAMP-1 (LC127058), Fugu uncharacterized protein (H2V4H1), Zebrafish LAMP-1 
(Q6P299), Japanese medaka uncharacterized protein (H2LIM4), Nile tilapia (I3J577), Amazon 
molly LAMP-1 (XP_007554035.1), Three-spined stickleback uncharacterized protein 
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(G3PRL1), Channel catfish LAMP-1 (W5UCE1), Salmon LAMP-1 (C0H980), Asian sea bass 
predicted LAMP-1 (XP_018539319.1), Bicolor damselfish predicted LAMP-1 
(XP_008273729.1), Black rockcod predicted LAMP-1 (XP_010784816.1), Southern platyfish 
uncharacterized protein (M4AXY6), Australian ghostshark LAMP-1 (V9KCK3), Mouse 
LAMP-1 (Q9DC13), Human LAMP-1 (NP_005552.3). N-linked glycosylation sites are 
continuous underlined and O-linked glycosylation sites are marked by asterisks. Conserved 
cysteine residues are boxed. 
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Figure 4. The Neighbor-joining phylogenetic tree of LAMP family members. The bootstrap 
analysis used 1000 replications. The amino acid sequences were obtained from Genbank 
accession numbers or Ensembl protein ID: Japanese flounder LAMP-1 (LC127058), Fugu 
uncharacterized protein (H2V4H1), Zebrafish LAMP-1 (Q6P299), Japanese medaka 
uncharacterized protein (H2LIM4), Nile tilapia (I3J577), Amazon molly LAMP-1 
(XP_007554035.1), Three-spined stickleback uncharacterized protein (G3PRL1), Channel 
catfish LAMP-1 (W5UCE1), Salmon LAMP-1 (C0H980), Southern platyfish uncharacterized 
protein (M4AXY6), Australian ghostshark LAMP-1 (V9KCK3), Mouse LAMP-1 (Q9DC13), 
Human LAMP-1 (NP_005552.3). Green spotted pufferfish chromosome 5 SCAF14581 
(Q4SHX6), Zebrafish LAMP2 (NP_001013551.1), Guppy predicted LAMP2 X1 
(XP_008418857.1), Fugu predicted LAMP2 X3 (XP_011609168), Japanese medaka predicted 
LAMP2 X3 (XP_011478225.1), Salmon LAMP2 (NP_001133282.1), Asian sea bass predicted 
LAMP-1 (XP_018539319.1), Bicolor damselfish predicted LAMP-1 (XP_008273729.1), 
Black rockcod predicted LAMP-1 (XP_010784816.1), Nile tilapia predicted LAMP2 X1 
(XP_005467465.1), Large yellow croaker predicted LAMP2 X2 (XP_010730273.1), Amazon 
molly predicted LAMP2 X2 (XP_007569760.1), Mummichog predicted LAMP2 
(XP_012717205.1), Tongue sole predicted LAMP2 (XP_008324674.1), Atlantic herring 
predicted LAMP2 X1 (XP_012697575), Australian ghostshark LAMP2 (NP_001279230.1), 
Bicolor damselfish predicted LAMP2 (XP_008274116), Northern pike predicted LAMP2 
(XP_010894624.1), Black rockcod predicted LAMP2 X2 (XP_010764723), Burton’s haplo 
LAMP-1
LAMP-3
LAMP-2
		
75	
predicted LAMP2 (XP_005913220), West Indian ocean coelacanth predicted LAMP2 
(XP_006003901.1), Zebra mbna predicted LAMP2 X3 (XP_004545812.1), Human LAMP2 
(AAB35426), Cattle – Bull LAMP3 (NP_001095605), Dog predicted LAMP3 X1 
(XP_848889.2), Zebrafish predicted LAMP3 (XP_001342688.2), Western clawed frog 
predicted LAMP3 (XP_002936919.2), Rat LAMP3 (NP_001012015.1), Mouse LAMP3 
(NP_796330.2), Rhesus macaque LAMP3 (NP_001028044.1), Human LAMP3 
(NP_055213.2). 
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Figure 5. Tissue expression of JfLAMP-1 mRNAs in Japanese flounder. a) Tissue samples 
were analyzed by RT-PCR. EF1α was used as internal control. Lanes: BL, Blood; G, Gills; B, 
Brain; M, Muscle; L, Liver; S, Spleen; I, Intestine; K, Kidney, 25 cycles. b) qPCR analysis of 
JfLAMP-1 expression in Japanese flounder tissues. All data were normalized to EF-1α and 
blood expression set as 1. Error bars indicate standard error of the mean. Asterisks indicate 
statistical difference (*p<0.05). 
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Figure 6. qPCR analysis of JfLAMP-1 expression in spleen from Edwardsiella tarda FKC-
injected Japanese flounder at different time points at 22℃. All data were normalized to EF-1α. 
Error bars indicate standard error of the mean. Asterisks indicate statistical difference respect 
to 0h (*p<0.05; **p<0.01). 
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Figure 7. qPCR analysis of JfLAMP-1 expression in spleen from Edwardsiella tarda FKC-
injected Japanese flounder at different time points at 15℃. All data were normalized to EF-1α. 
Error bars indicate standard error of the mean. Asterisks indicate statistical difference respect 
to 0h (**p<0.01). 
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Figure 8. qPCR analysis of JfLAMP-1 expression in spleen from Poly I:C-injected Japanese 
flounder at different time points at 22℃. All data were normalized to EF-1α. Error bars indicate 
standard error of the mean. 
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Figure 9. Expression of JfLAMP-1 in HINAE cells. a) JfLAMP-1 mRNAs in HINAE cells. 
EF1α was used as internal control (25 cycles). b) Western blot analysis of the expression of 
rJfLAMP-1. rJfLAMP-1 appeared as a band of 44 kDa. c) Western blot analysis of the 
expression of JfLAMP-1 in HINAE cells. JfLAMP-1 appeared as a band of 56 kDa,  
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Figure 10. Expression of JfLAMP-1 in HINAE cells. Immunofluorescence staining for 
JfLAMP-1 in HINAE cells. A. Negative control without anti-JfLAMP-1 primary antibody. B 
& C. Expression of JfLAMP-1 in HINAE cells, JfLAMP-1 appears distributed in the 
cytoplasmic granules of different sizes and frequently grouped at the perinuclear zone. Hoechst 
stain was used to stain the nucleus. Bar: 10 µm. 
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Chapter 3 
 
 
 
 
LAMP1-chimeric DNA vaccine enhances the antibody response in 
Japanese flounder, Paralichthys olivaceus 
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Abstract 
DNA vaccination is an effective alternative against viral and bacterial diseases in fish farming 
that has shown promising results and gives some advantages compared with the conventional 
ones. Currently, chimeric antigens in a DNA vaccine have been reported to increase the 
protection against viral diseases. In this study, the lysosome-associated membrane protein-1 
from Japanese flounder, Paralichthys olivaceus, (JfLAMP-1) was used in a chimeric DNA 
vaccine fused with the major capsule protein (MCP) from red seabream iridovirus - RSIV. In 
the first experiment, JfLAMP-1 and MCP gene were hybridized by replacing the JfLAMP-1 
luminal domain with MCP and subsequent cloning in an expression vector (pCIneo). In the 
second experiment, the luminal domain of JfLAMP-1 gene was kept and the MCP gene as 
inserted. Fish vaccinated with the chimeric vaccines showed significantly higher antibody 
levels than fish vaccinated with pCIneo vector harboring the MCP gene (p<0.05). This study 
highlights the opportunity to use LAMP-1-associated chimeric vaccines as an alternative to 
enhance the immune response against viral pathogens. 
 
Keywords: Antibody response, chimeric antigens, DNA vaccine, iridovirus, Japanese flounder 
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1. Introduction 
In the last decades, global fish, shellfish and algae production has grown simultaneously 
with the world per capita seafood consumption (FAO, 2014; Micha et al., 2015) and fish 
become an important food supply source for human beings (Godfray et al., 2010; Olesen et al., 
2015). However, the intensive culture systems in farmed fish elicit a high vulnerability to 
infectious diseases and there is not a unique strategy to control them, due to the particular 
diversity of the environmental conditions for every country and every culture system as well as 
outbreaks of different strains of pathogens (Kibenge et al., 2012; Shinmoto et al., 2009). In case 
of viral diseases, the control is more difficult due to the high susceptibility of aquatic animals 
at an early age, the lack of therapeutics, insufficient knowledge of the pathogenesis of viral 
infection and limited knowledge of natural resistance mechanisms in aquatic animals (Kibenge 
et al., 2012). Nevertheless, several strategies are employed in fish farming to prevent and 
control viral diseases including selective breeding of resistant fish families (Gjedrem, 2015; 
Olesen et al., 2015), vaccination (Fu et al., 2012; Yasuike et al., 2011; Zheng et al., 2016) and 
feed additives (Falco et al., 2013; Yeh et al., 2008).  
 
Iridoviridae is one of the more important emerging virus family that affects fish and 
amphibians (Chinchar, 2002; Chinchar et al., 2009). From this family, Megalocytivirus genus 
infects a wide range of tropical marine and freshwater fish and includes several species that 
affect fish such as red sea bream iridovirus (RSIV), infectious spleen and kidney necrosis virus 
(ISKNV) and orange spotted grouper iridovirus (OSGIV) (Kurita & Nakajima, 2012; 
Whittington et al., 2010). RSIV has been shown to infect more than 30 species of farmed marine 
fish (e.g. sea bass, Japanese flounder, amberjack, yellowtail) causing mortality and important 
economic losses in Southeast Asia (Do et al., 2005; Ito et al., 2013; Nakajima & Kurita, 2005; 
Nakajima et al., 1997). In Japan probably the importation of infected seedlings captured in the 
South China Sea was responsible for the introduction of the RSIV in the country (Chinchar et 
al., 2009) and the disease occurs mainly in the summer, in relatively high water temperatures 
(Kurita & Nakajima, 2012). 
 
For control the RSIV disease, a commercial formalin-inactivated vaccine was developed 
for fish (Nakajima et al., 1999; Nakajima et al., 1997) which rendered protection against the 
experimental challenge but has the limitation in the amount of viral copies able to produce in 
cell culture as well as that most of infected cells fail to express viral structural proteins and lost 
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the infectivity after several passages in culture (Kurita & Nakajima, 2012). In the same way, 
formalin-inactivated virus vaccines have shown low induction of cell-mediated immunity and 
poor immunogenicity (Davis & McCluskie, 1999) and recently were demonstrated different 
levels of protection against challenge depending on the viral strain (Shinmoto et al., 2009). 
Alternative inactivation reagents have been tested in iridoviral diseases with similar results (Ou-
yang et al., 2012) 
 
Previously, a RSIV DNA-free heat-denatured protein and a vaccine component that was 
DNA-free but with a structurally altered protein were assessed against RSIV challenge showing 
lower protection than the formalin-inactivated vaccine but similar neutralizing antibody level 
and gene expression induction (Caipang et al., 2006a). On the other hand, several studies using 
vaccination based on recombinant protein antigens (Caipang et al., 2006a; Drennan et al., 2007; 
Shimmoto et al., 2010) and DNA vaccines (Caipang et al., 2006b; Zheng et al., 2016) have 
been reported in order to increase the immunity against iridoviral pathogens. Recombinant 
RSIV’s major capsid protein (MCP) subunits (r18P, r351P, and rMCP) were evaluated as 
subunit vaccines in red sea bream (Pagrus major) showing variable protection levels with 
survival rates from 27-52% after RSIV challenge, but higher that those showed by control group. 
For DNA vaccines, a DNA vaccine encoding for two different RSIV’s ORFs showed similar 
protection to formalin-inactivated RSIV vaccinated group (Caipang et al., 2006b). Thus, the 
alternatives to increase the protection against RSIV require new approaches that improve the 
efficacy at an appropriated cost:benefit ratio 
 
Recently, DNA vaccine-encoding chimeric antigens have shown promising results in animal 
models against viral and bacterial diseases (Deb et al., 2015; Dhalia et al., 2009; Klucar et al., 
2009). Among them, the use of lysosome associated membrane protein (LAMP)-chimeric 
vaccines have been assessed against viral pathogens rendering enhanced immune response 
(Arruda et al., 2006; de Arruda et al., 2004; Dhalia et al., 2009; Marques et al., 2003). 
Lysosomal membrane proteins are highly glycosylated (Fukuda, 1991; Hatakeyama et al., 
2014) and it was estimated that lysosome associated membrane proteins (LAMPs) and 
lysosome integrated membrane proteins (LIMP) constitute about 50% of all proteins in 
lysosomal membrane (Hunziker et al., 1996; Marsh et al., 1987) and some of them can be 
expressed on the cell surface (Furuta et al., 1999; Hatakeyama et al., 2014; Tompkins et al., 
2006). The sorting of LAMPs resides in a short terminal tail (10-11 amino acids), which is 
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exposed, on the cytoplasmic side of the membrane (Dahlgren et al., 1995) and their tissue 
distribution differs between organs (Furuta et al., 1999). Besides of its function as interacting 
molecules LAMP-1 showed to protect natural killer cells from the degranulation-associated 
damage (Cohnen et al., 2013). The aim of this study was to show the potential use of Japanese 
flounder LAMP-1 (JfLAMP-1) as a chimeric DNA vaccine carrier to enhance the antibody 
response against RSIV. 
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2. Material and methods 
 
2.1. Plasmid DNA construction and preparation  
The cloning and sequence of JfLAMP-1 was described in the chapter 2. The full length of 
major capsid protein (MCP) gene of red seabream iridovirus was amplified by PCR from a 
recombinant plasmid containing MCP using specific primers with NdeI and EcoRI restriction 
enzymes sites (Table 1), cloned into pGEM T-easy vector (Promega, USA) and transformed in 
E. coli JM109 strain (Wako, Japan). Plasmid was extracted and double digested with 
corresponding enzymes, purified by electrophoresis and inserted in a pCIneo vector (Promega, 
USA) digested with the same restriction enzymes. The recombinant plasmids were sequenced 
using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, USA) with a 
3130xl genetic analyzer (Applied Biosystems, USA). pCIneo vector harboring MCP gene 
(pCMCP) and pCIneo were purified from overnight cultures. 
 
Plasmid was purified by cesium chloride (CsCl) density gradient centrifugation (Noles, 
2008; Pollard & Grady, 1967). For each vaccination treatment, E. coli JM109 strain-containing 
a recombinant plasmid was cultured overnight at 37 ℃ in 2 ml of 2x YT broth containing 
ampicillin. Then, overnight culture was transferred to a flask with 200 ml of 2x YT broth with 
ampicillin and cultured for 18 h at 37 ℃. After culture, cells were harvested at 5000 rpm for 10 
min at 4 ℃. Plasmid was extracted from the bacterial pellet by alkaline lysis method. After, 
isopropanol and ethanol precipitation, pellet was digested by RNAse at 37 ℃ for 1 h and CsCl 
(3.88 g) was added after digestion. This mixture was placed into an OptiSeal tube (Beckman 
Coulter, USA) and ethidium bromide (100 µl) and Tris-EDTA (TE) buffer were added until the 
tube was filled out completely. Tube was under ultracentrifugation at 65,000 rpm for 20 h at 
20 ℃ and the plasmid DNA layer was collected by puncture with a needle. Ethidium bromide 
was removed with saturated 2-propanol and the sample dialised by using dialysis bag in TE 
buffer. 
 
2.2. Construction of pCLAMP-MCP and pCLAMP-MCPLumD vaccines 
For production of chimeric DNA vaccine of JfLAMP1-MCP (pCLAMP-MCP), primers 
were designed to hybridize the JfLAMP-1 and iridoviral MCP gene (Table 1), based on an 
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overlapping of the sequences at the ends (Grandori et al., 1997). MCP gene from iridovirus was 
inserted into the JfLAMP-1 gene by replacing the luminal domain from JfLAMP-1 and 
subsequent hybridization of the genes in the remaining domains. For that, signal peptide from 
JfLAMP-1 was fused with 5’-end of MCP and 3’-end of MCP was hybridized with 5’-end of 
transmembrane domain/cytoplasmic domain of JfLAMP-1 (Figure 1). Signal peptide, MCP and 
transmembrane domain/cytoplasmic domain were amplified by separated and fused by pairs. 
Restriction enzymes sites (NdeI and EcoRI) were added at the end of JfLAMP-1 and the PCR 
product was cloned in cloned into pGEM T-easy vector (Promega, USA). After restricted 
digestion of the plasmid, the chimeric gene insert was cloned in a pCIneo vector (Promega, 
USA) digested with the same restriction enzymes and its sequence was verified. For the 
pCLAMP-MCPLumD vaccine, the luminal domain (LumD) of JfLAMP-1 gene was kept and 
the MCP gene was inserted (Figure 1c). 
 
2.3. Vaccination experiments 
For vaccination experiments, Japanese flounder with an average size 10 cm in total length 
were acclimated and reared at 18 ℃ in artificial seawater for a week prior the start of the 
experiments. In the pCLAMP-MCP vaccination, experimental animals were distributed in three 
groups and injected intramuscularly with 10 µg of pcMCP; 10 µg of pCLAMP-MCP, and pCI-
neo vector (negative control) in 50 µl of saline buffer near to the dorsal fin. On the other hand, 
in the pCLAMP-MCPLumD vaccination, experimental animals were distributed in six groups 
and injected intramuscularly with 10 µg of pcMCP; 10 µg of pCLAMP-MCP, 10 µg of 
pCLAMP-MCPLumD and as negative control pCI-neo vector, pCLAMP, PBS were used, in 
50 µl of saline buffer.  
 
The presence of MCP in muscle at 3rd day post-injection was confirmed by RT-PCR using 
muscle cDNA as template and RSIV MCP specific primers (Table 1). For this, total RNA was 
extracted from muscle of vaccinated Japanese flounder using RNAiso plus reagent (Takara Bio. 
Inc., Japan). cDNA was synthesized using SuperScript™ III First Strand synthesis system M-
MLV (Life Technologies, USA). RT-PCR was performed with cDNA templates (5 times 
diluted) from each tissue using specific primer sets under the following PCR conditions: initial 
denaturation at 95 °C for 4 min, followed by 25 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 °C 
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for 1 min and a final extension of 72 °C for 7 min. EF-1α gene was used as an internal control. 
The PCR products were electrophoresed on 2% agarose gels.  
2.4. Analysis of antibody response 
At day 30 post-vaccination, fish from each group were assayed for antibody response 
against MCP by enzyme-linked immunosorbent assay (ELISA) according to Taechavasonyoo 
et al. (2013). Briefly, a 96-well plate was coated 2 h at 25 °C with rMCP (20 µg/ml) in 100 µl 
of PBS. The plate was washed three times with PBS-T (PBS containing 0.05% Tween 20) and 
then blocked overnight with 5% bovine serum albumin (BSA, Sigma-Aldrich, Germany) in 
PBS at 4 °C. After washing three times with PBST, the diluted sera (1:20) obtained from 
individually vaccinated fish were added to wells of the plate and incubated at 25 °C for 1 h. 
The plate was then washed thrice and rabbit anti-Japanese flounder immunoglobulin M serum 
(1:3000) was added to the plate, and incubated at 25 °C for 1 h. After washing thrice, alkaline 
phosphatase-conjugated goat anti-rabbit IgG (1:1000) (Promega, Madison, WI) was added to 
the wells and incubated at 25 °C for 1 h. The reaction was developed by addition of AP substrate 
(Sigma-Aldrich, Germany) and stopped by addition of 3 M NaOH. The absorbance was then 
measured with a microtiter plate reader (Multiskan Go, Thermo Scientific, Finland) at the 
wavelength of 405 nm. 
 
2.4. Statistical analysis 
A statistical analysis for antibody response was performed by one-way ANOVA and 
Tukey’s multiple comparisons of the means were done (GraphPad Prism Version 6.0 for 
Windows, USA). Differences were considered statistically significant when p < 0.05. 
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3. Results 
 
At the 3rd day of vaccination, MCP gene was detected by RT-PCR, in the pCMCP, 
pCLAMP-MCP and the pCLMPA-MCPLumD groups. The pCLAMP-MCPLumD showed a 
weaker band compared with the other 2 groups (Figure 3a). The muscle samples from PBS, 
pCIneo and pCLAMP groups were negative to MCP gene.  
 
3.1. Antibody response in vaccination 
Antibody levels against RSIV MCP in serum showed that pCLAMP-MCP elicited 
significant higher antibody response compared with pCMCP and the pCIneo (Figure 2). In the 
second experiment, the inclusion of the LumD in the chimeric vaccine showed to induce higher 
antibody titers against RSIV MCP compared with pCMCP, pCLAMP, pCIneo and PBS groups, 
however the antibody levels were higher but not statistically different compared with the 
pCLAMP-MCP (Figure 3b). 
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4. Discussion 
 
Vaccination is one of the prophylactic strategies applied in aquaculture to increase the 
protection against diseases (Newman, 1993; Sommerset et al., 2005). In fish, several vaccines 
have been tested with variable results (Byon et al., 2005; Byon et al., 2006; Hølvold et al., 
2014; Ou-yang et al., 2012; Penaranda et al., 2011; Shin et al., 2013; Sommerset et al., 2005; 
Sun et al., 2010; Tonheim et al., 2008) and DNA vaccines have shown some advantages and 
high level of protection compared with the conventional modified/inactivated antigen-based 
vaccines (Byon et al., 2006; Martinez-Lopez et al., 2014; Tonheim et al., 2008; Yasuike et al., 
2007), including that are relatively inexpensive and easy to produce, and can be manufactured 
using identical production processes (Tonheim et al., 2008). Recently, chimeric antigens in 
DNA vaccines were proposed as an alternative to increase the immune response against 
parasitic, bacterial and viral pathogens (Grigera et al., 1996; Nawaratna et al., 2015; 
Starodubova et al., 2010). In this study, a JfLAMP-1-MCP DNA vaccines (pCLAMP-MCP and 
pCLAMP-MCPLumD) were tested for their ability to induce antibody response in Japanese 
flounder. The results showed that the pCLAMP-MCP and pCLAMP-MCPLumD chimera DNA 
vaccine elicited significant higher antibody levels in serum against MCP than the pCMCP. 
These results are in agreement with studies in which LAMP-chimeric antigens in a DNA 
vaccine induced higher antibody titers than the single plasmid-encoding antigen in murine 
models (Arruda et al., 2006; de Arruda et al., 2004; Marques et al., 2003). 
 
In the present study, pCLAMP-MCPLumD induced higher anti-MCP antibodies compared 
with the pCMCP, however the antibody titers were not higher than pCLAMP-MCP. Previously, 
Marques et al. (2003) the inclusion of LumD of LAMP-1 in a chimeric vaccine induce higher 
antibody titer than one without it. This higher induction was correlated with a resistance to the 
early proteolysis (Arterburn et al., 1990) or biased trafficking of the antigen through major 
histocompatibility complex (MHC) class II pathway (Arruda et al., 2006; Marques et al., 2003) 
 
DNA vaccines have the ability to stimulate both cellular and humoral immunity (Wang et 
al., 1998). However, since the antigens expressed in DNA vaccine are produced inside the cells 
commonly they are processed in MHC class I pathway which induce mainly cytotoxicity 
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response (Tonheim et al., 2008). By using LAMP as a carrier molecule is possible to drive the 
traffic of the antigen to the MHC class II processing pathway, to expose cryptic epitopes 
(Arruda et al., 2006; Starodubova et al., 2010) and to enhance the CD4+ T cell 
priming/activation which is vital for the function of genetic vaccines (Arruda et al., 2006). The 
co-localization of LAMP-chimeric antigen from a DNA vaccine and MHC class II has been 
demonstrated in previous studies (Anwar et al., 2005; Arruda et al., 2006; de Arruda et al., 
2004; Marques et al., 2003). The optimization antigen expression/traffic will allow to reduce 
the amount/concentration of DNA vaccine dose used in in vivo immunization (Dhalia et al., 
2009) and the “labeling” of the antigens with specialized signal sequences can be an alternative 
in order to enhance the immune response against pathogens in fish. 
 
In conclusion, the use of JfLAMP-1 as an antigen carrier in a DNA vaccine showed to 
enhance the antibody immune response against iridoviral MCP, compared with the 
conventional DNA vaccine and can be an alternative to study in the design of new approaches 
to fish vaccination. 
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Table 1. PCR primers used in this study. 
Target Usage Primer sequence (5′–3′)* 
JfLAMP ORF Cloning F AACATATGGAACTCTCTCACACGGT 
 Cloning R GAATTCGATGGTCTGGTATCC 
EF1α RT PCR/qPCR F CTCGGGCATAGACTCGTGGT 
 RT PCR/qPCR R CATGGTCGTGACCTTCGCTC 
MCP Cloning F GGGCATATGTCTGCAATCTCAGGTGC 
 Cloning R CCCGAATTCTTAATGATGATGATGAT 
 RT-PCR F ATCAAAACAGACTGGCCATGCTAAT 
 RT-PCR R AAATTATCACACCAGCGAATGTAGC 
LAMP-SigPep (MCP)** Hybridization R GATCGCAGACATAGCCTGAATACAA 
(LAMP-SigPep) MCP Hybridization F TTGTATTCAGGCTATGTCTGCGATC 
MCP (LAMPTrasDom) Hybridization R GGGATGAGCATCAGGATAGGGAAGC 
(MCP) LAMPTrasDom Hybridization F GCTTCCCTATCCTGATGCTCATCCC 
MCP (LAMPLumD) Hybridization R GGACCAGGACCAGATGGTACGCAAA 
(MCP) LAMPLumD Hybridization F CTTTGCGTACCATCTGGTCCTGGTCC 
*Restriction enzyme sites (NdeI and EcoRI) are underlined at the start of the sequence. 
**Between parentheses appear the position of the gene which nucleotides are added in order to 
hybridize at the ends of each domain. 
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Figure 1. Schematic representation of the expression plasmids used for vaccination experiments. 
a) pCMCP, pCIneo harboring RSIV MCP gene. b) pCLAMP-MCP, pCIneo harboring the 
chimeric antigen, luminal domain (LumD) from JfLAMP-1 was replaced with RSIV MCP gene 
c) pCLAMP-MCPLumD, pCIneo harboring the chimeric antigen, RSIV MCP gene was 
inserted between LumD and transmembrane domain (T) of JfLAMP-1. SP, signal peptide 
domain; T+C, Transmembrane +Cytoplasmic domain. 
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Figure 2. Antibody levels in vaccinated Japanese flounder. Antibody response against MCP in 
Japanese flounder. Serum samples were taken 30 days after vaccination and anti-MCP antibody 
level was measured in by ELISA at 405 nm. Different letters denote significant differences. 
Dilution 1:20. OD, Optical density. 
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Figure 3. Antibody levels in vaccinated Japanese flounder with chimeric DNA vaccines. a) 
RSIV MCP expression in muscle sample after 3 days of vaccination detected by RT-PCR. EF1a 
gene was used as reaction as internal control (28 cycles). b) Antibody response against MCP in 
Japanese flounder. Serum samples were taken 30 days after vaccination and anti-MCP antibody 
level was measured in by ELISA at 405 nm. Different letters denote significant differences. 
Dilution 1:20. OD, Optical density. 
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Chapter 4 
 
 
 
 
LAMP1-chimeric DNA vaccine protection against fish diseases 
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Abstract 
The use of chimeric antigens in a DNA vaccine that come for the hybridization with sorting 
signals have shown promising results in animal models, in which sorting motifs drive the 
movement of the antigens inside the cell. In the present study, lysosome-associated membrane 
protein-1 from Japanese flounder, Paralichthys olivaceus, (JfLAMP-1) which has a high 
identity with LAMP-1 from striped beakfish, Oplegnathus fasciatus, was used as a carrier for 
the major capsid protein (MCP) from red sea bream iridovirus (RSIV) in order to evaluate its 
potential as DNA chimeric vaccine. JfLAMP-1 was fused with the MCP from RSIV to produce 
a chimeric DNA vaccine. For this, striped beakfish individuals were distributed in four 
experimental groups: PBS, pCIneo, pCMCP and pCLAMP-MCP and after 30 days of 
vaccination, a challenge test was performed by using RSIV in low and high dose. In the 
vaccinated group challenged with low dose of RSIV, pCMCP and pCLAMP-MCP showed 
similar relative percentage of survival of 13%, however in the high dose challenge, pCLAMP-
MCP vaccinated group showed relative percentage of survival of 19%, compared with 0% of 
the pCMCP. In this chapter, a preliminary experiment to evaluate the protection of a chimeric 
DNA vaccine against Edwardsiella tarda. In conclusion, chimeric DNA vaccines using sorting 
signals from specific molecules can be candidates to enhance the immune response against 
specific pathogens, for example, by modulation of the traffic of antigen. 
 
Keywords: Chimeric antigens, DNA vaccine, iridovirus, striped beakfish 
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1. Introduction 
Iridoviruses are large double stranded DNA viruses that infect a wide range of vertebrates 
(Chinchar et al., 2009; Eaton et al., 2010). In marine and freshwater fish, several iridoviruses 
belonging to the Megalocytivirus genus have been reported (Whittington et al., 2010). From 
them, red sea bream iridovirus (RSIV) has been shown to infect several species of farmed 
marine fish causing mortality and important economic losses in Southeast Asia (Do et al., 2005; 
Ito et al., 2013; Nakajima & Kurita, 2005; Nakajima et al., 1997).  
 
RSIV was first isolated from cultured red sea bream in Shikoku island in Japan, which 
showed inactive swimming and severe anemia with 20-60% of mortality (Inouye et al., 1992). 
In Japan probably the importation of infected seedlings captured in the South China Sea was 
responsible for the introduction of the RSIV in the country (Chinchar et al., 2009) and the 
disease occurs mainly in the summer, in relatively high water temperatures (Ito et al., 2013; 
Kurita & Nakajima, 2012). The increase trade and movement of several fish species amplifies 
the risk of spread the RSIV in asymptomatic latently infected fish (Kyung et al., 2006) 
 
RSIV infection affects mainly juvenile fish and causes anemia, gill hemorrhage and 
splenomegaly (Inouye et al., 1992; Nakajima & Kurita, 2005). RSIV shows a systemic spread 
to several organs with hypertrophy of large number of cells often situated near to vascular 
spaces where the degenerative and necrotic changes occur (Gibson-Kueh et al., 2003). PCR, 
nested PCR and indirect immunofluorescence assays have been used for the diagnosis (Kyung 
Choi et al., 2006; Nakajima & Kurita, 2005) Spleen is considered the organ of choice for 
diagnosis and after infection the quantity of RSIV DNA is higher than other tissues in Japanese 
amberjack (Ito et al., 2013). Nevertheless, Kyung et al. (2006) showed the detection of the virus 
in heart, stomach, intestine, muscle, eyes and gills rather than spleen in asymptomatic 
rockbream (Oplegnathus fasciatus). This highlights the possibility of differential kinetic of the 
virus depending on the species. 
 
For control the RSIV disease, a commercial formalin-inactivated vaccine was developed 
and used in juvenile marine fish (Nakajima et al., 1999; Nakajima et al., 1997) which rendered 
protection against the experimental challenge but has the limitation in the amount of viral copies 
able to produce in cell culture as well as that most of infected cells fail to express viral structural 
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proteins and lost the infectivity after several passages in culture (Kurita & Nakajima, 2012). 
Recently, it was demonstrated different levels of protection against challenge depending on the 
viral strain (Shinmoto et al., 2009) which demand the design of vaccine of methods of 
vaccination that render consistent results. 
 
Chimeric antigens encoded in a DNA vaccine have shown promising results in animal 
models (Deb et al., 2015; Dhalia et al., 2009; Klucar et al., 2009). Among them, the use of 
lysosome associated membrane protein (LAMP)-chimeric vaccines have been assessed against 
viral pathogens rendering enhanced immune response (Arruda et al., 2006; de Arruda et al., 
2004; Dhalia et al., 2009; Marques et al., 2003). In the chapter 3, it was demonstrated that 
JfLAMP-1 used in a chimeric vaccine enhanced the antibody titers against RSIV major capsid 
protein (MCP). Based on this, the aim of this study was to show the potential use of JfLAMP-
1 as a chimeric DNA vaccine carrier to protect striped beakfish from RSIV challenge. In 
addition, a preliminary experiment of the chimeric vaccine against Edwardsiella tarda in 
Japanese flounder was carried out. 
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2. Material and methods  
 
2.1. Stripped beakfish LAMP-1 Cloning 
Based on EST analyses of Stripped beakfish transcripts primers were designed to amplify the 
open reading frame (ORF) of Stripped beakfish (SbLAMP-1) (Table 1) and cDNA from spleen 
was used as a template. PCR products were ligated and cloned into pGEM T-easy vector 
(Promega, USA) and sequenced using a BigDye Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems, USA) with a 3130xl genetic analyzer (Applied Biosystems). Putative 
signal peptide was predicted using SignalP (http://www.cbs.dtu.dk./services/SignalP/) and 
InterproScan was used to predict the domains (luminal, transmembrane and cytoplasmic) 
(http://www.ebi.ac.uk/interpro/). NetNGlyc and NetOGlyc programs were used for prediction 
of N-linked and O-linked glycosylation sites (http://www.cbs.dtu.dk./services/NetNGlyc/, 
http://www.cbs.dtu.dk./services/NetOGlyc/). Sequence alignments were generated using 
GENETYX-MAC 16.0.7 software (Software Development Co., Ltd., Tokyo, Japan) and 
Geneious® 8.1.7 (Biomatters Limited) (Kearse et al., 2012). Previously it was probed that 
Japanese flounder lysosome-associated membrane protein-1 (JfLAMP-1) works as a carrier in 
a DNA vaccine to increase the antibody production against RSIV MCP (chapter 3). Because 
LAMP-1 from stripped beakfish (Oplegnathus fasciatus) shows high identity with JfLAMP-1, 
I hypothesize that JfLAMP-1 can be used as a carrier for a chimeric vaccine in this species.  
 
2.2. Plasmid DNA for RSIV MCP vaccination  
The full length of major capsid protein (MCP) gene of red seabream iridovirus was 
amplified by PCR from a cDNA template using specific primers with NdeI and EcoRI 
restriction enzymes sites (Table 1), cloned into pGEM T-easy vector (Promega, USA) and 
transformed in E. coli JM109 strain (Wako, Japan). Plasmid was extracted and double digested 
with corresponding enzymes, purified by electrophoresis and inserted in a similar restricted 
pCIneo vector (Promega, USA). The recombinant plasmids were sequenced using a BigDye 
Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, USA) with a 3130xl genetic 
analyzer (Applied Biosystems). pCIneo vector harboring MCP gene (pCMCP), pCLAMP-MCP 
and pCIneo were purified from overnight cultures as described previously in the chapter 3. 
 
 
		
108	
2.2.1. pCLAMP-MCP vaccination experiment 
The construction of the chimeric vaccines was based on an overlapping of the sequences 
at the ends (Grandori et al., 1997), same as described in chapter 3. Experimental animals 
(n=120) were distributed in three groups and injected intramuscularly with 10 µg of pcMCP; 
10 µg of pCLAMP-MCP, and pCI-neo vector (negative control) in 50 µl of saline buffer near 
to the dorsal fin.  
 
2.3. Viral copy number 
The copy number was determined by qPCR through standard curve method (Caipang et 
al., 2003). For this, serial dilutions of a known concentration of plasmid harboring RSIV MCP 
gene was used to quantify the Ct value of the dilution. Ct values and the concentration of 
plasmid (in each serial dilution) was plotted and a standard curve was constructed. For qPCR, 
specific primer set for MCP (Table 1) was designed and the reaction was carried out using 
SYBR green PCR master mix (Applied Biosystems) on a StepOnePlus Real-time PCR system 
(Applied Biosystems) according to the manufacturer's protocol.  
 
2.4. Challenge test  
30 days after vaccination, fish were separated in two experimental challenge groups (n=60) 
by each treatment: high dose (viral copy number= 1.83 x104/ml) and low dose (viral copy 
number= 1.75 x103/ml). Animals were i.p. injected with 100 µl of the viral suspension and the 
mortality was monitored daily. 
 
2.5. pCLAMP-Eta2 vaccination preliminary experiment 
A JfLAMP-1-chimeric DNA vaccine was constructed using Eta2 gene from Edwardsiella 
tarda as antigen. For this, Eta2 gene was amplified using specific primers with restriction 
enzymes sites, cloned into pGEM T-easy vector (Promega, USA) and transformed in E. coli 
JM109 strain (Wako, Japan). Plasmid was extracted and digested with the corresponding 
enzymes, purified by electrophoresis and inserted in a pCIneo vector (Promega, USA) digested 
with the same restriction enzymes.  
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pCLAMP-Eta2 DNA vaccine was constructed by insertion of Eta2 between the regions 
that code for the luminal domain and the transmembrane domain of JfLAMP-1 gene, by using 
overlapping of the sequences at the ends (Grandori et al., 1997), as described in chapter 3. In 
addition, two DNA vaccines were constructed by adding the medaka beta actin promoter 
(mbac) to the plasmid, i.e. pCmbacEta2 and pCmbacLAMP-Eta2 (Figure 2). The recombinant 
plasmids were sequenced and purified from overnight cultures as described in chapter 3. 
Specific primer sets are listed in table 1. 
 
2.5.1. Eta2 vaccination and bacterial challenge 
Japanese flounder with an average size 10 cm in total length were acclimated and reared at 
18 ℃ in artificial seawater for a week prior the start of the experiments. 5 groups were used as 
follows: pCIneo, pCEta2, pCLAMP-Eta2, pCmbacEta2 and pCmbacLAMP-Eta2. Each group 
had 10 individuals which were injected intramuscularly with 10 µg of each recombinant 
plasmid in 50 µl of saline buffer near to the dorsal fin. 
After 15 days of vaccination, animals were challenged with Edwardsiella tarda strain 
NUF806 by i.p injection of 100 µL of a bacterial suspension in saline buffer with a total 
concentration of 6 x 107 colony forming units. The mortality was monitored every 12 h. 
 
2.6. Statistical analysis 
A statistical analysis for survival rate was performed by Kaplan-Meier analysis (GraphPad 
Prism v6.0 for MacOS, California, USA). Differences were considered statistically significant 
when p < 0.05. The relative percentage of survival (RPS) was calculated as RPS= (1- 
(%mortality of immunized group / %mortality of non-immunized group))*100. 
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3. Results 
 
3.1. SbLAMP-1 cloning 
SbLAMP-1 gene has an ORF of 1248 bp that codes for 415 aa with a predicted molecular 
weight of 43.694 kDa. The 3’UTR had a polyadenylation signal (AATAA) 414 bp downstream 
of the translation termination codon (TGA). SbLAMP-1 contains a signal peptide and 3 
domains: luminal domain, transmembrane domain and cytoplasmic domain. 17 predicted N-
glycosylation sites and 46 predicted O-glycosylation sites were detected. Pairwise alignment of 
SbLAMP-1 with JfLAMP-1 showed 81% of amino acid identity. Transmembrane and 
cytoplasmic domain were highly conserved and the HAGYQTI motif was found at the 
cytoplasmic domain. In the same way, eight conserved cysteine residues were present. Based 
on the higher identity and conserved domains among the LAMP-1, JfLAMP-1 was used as a 
carrier of RSIV MCP in a DNA vaccine on stripped beakfish. 
 
3.2. Viral copy number 
The values obtained for the standard curve in the viral copy number were: Slope= 3.211, 
Y-Inter= 9.519, R2= 0.985, Efficiency= 104.82 %, Threshold= 1.153 (∆Rn) and Tm= 83.63. 
 
3.3. Challenge test 
In the vaccination and challenge experiment with RSIV in striped beakfish at low dose the 
pCLAMP-MCP vaccinated group showed a RPS of 13% (Figure 3). On the other hand, in the 
high dose challenge experiment, pCLAMP-MCP vaccinated group showed RPS of 19%, 
compared with 0% of the pCMCP group (Figure 4).  
 
For Eta2 DNA vaccination in Japanese flounder, after challenge almost all the fish died 
before 120 h. However, the pCLAMP-Eta2 group showed a slower mortality rate that last until 
168 h (Figure 5). 
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4. Discussion 
 
Vaccination against iridovirus have shown to elicit good protection for viral challenge 
(Drennan et al., 2007; Ou-yang et al., 2012a; Ou-yang et al., 2012b; Shin et al., 2013; Zheng 
et al., 2016). In case of RSIV, formalin-inactivated vaccine induced protection in red sea bream, 
amberjack and seriola species (Nakajima et al., 2002; Nakajima et al., 1999). However, in these 
studies the supernatant from RSIV-infected grunt fin cell line culture was used which mass 
production is difficult and expensive (Nakajima et al., 1997). On the other hand, DNA 
vaccination against RSIV showed similar protection that inactivated vaccines. Caipang et al. 
(2006) found that a RSIV gene encoding a major capsid protein (MCP), and an open reading 
frame containing a transmembrane domain when used as DNA vaccines were both 
immunogenic and protective against viral challenge. However, in Oplegnathus genus fish 
species, which are highly susceptible to the RSIV infection, the vaccination efficacy by either 
type of vaccine is lower or absent (Matsuyama et al., 2016).  
 
Recently, chimeric antigens in DNA vaccines were proposed as an alternative to increase 
the immune response against pathogens (Grigera et al., 1996; Nawaratna et al., 2015; 
Starodubova et al., 2010). In the present study, a DNA vaccine coding for a chimeric antigen 
of JfLAMP-1 and RSIV MCP induced a RPS of 19% which was higher than the conventional 
DNA vaccine (0 %). This result showed the potential use of chimeric antigens in DNA vaccines 
using LAMP-1 or molecules containing sorting signals to improve the immunogenicity and 
protection of the vaccines.  
 
In the chapter 3 was demonstrated that JfLAMP-1 chimeric DNA vaccines induced higher 
antibody titers in vaccinated fish, which may be one of the mechanisms that render protection. 
Shimmoto et al. (2010) showed that a vaccine based on a chimeric antigen can give protection 
against the challenge with RSIV and that this protection may be mediated by neutralizing 
antibodies that block the entry of the virus and the spread to fish organs, since less accumulation 
of virus in tissues was found in vaccinated animals.  
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DNA vaccines have the ability to stimulate cellular as well as humoral immunity (Wang et 
al., 1998). In addition, LAMP as a carrier molecule can drive the traffic of the antigen to the 
MHC class II processing pathway, enhance the CD4+ T cell priming/activation (Arruda et al., 
2006; Starodubova et al., 2010) and co-localize with MHC class II (Anwar et al., 2005; Arruda 
et al., 2006; de Arruda et al., 2004; Marques et al., 2003).  
 
The LAMP-1 chimeric DNA vaccine against E. tarda by using Eta2 as antigen, requires 
adjustment in the challenge dose, which was higher for the size of the animals. The use of lower 
dose may allow to find an effect of the vaccine, since the experimental animals are challenged 
with a concentration that allow the animal to start an immune response and mimic the situation 
in a natural infection.  
 
In conclusion, the use of JfLAMP-1 as an antigen carrier in a DNA vaccine elicited higher 
protection against RSIV than the conventional DNA vaccine in striped beakfish. 
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Table 1. PCR primers used in this study. 
 
Target Usage Primer sequence (5′–3′)* 
SbLAMP-1 ORF Cloning F ATGAAACTCTGTCACGCTTTGGC 
 Cloning R TCAGATGGTCTGGTATCCGGCGT 
MCP Cloning F GGGCATATGTCTGCAATCTCAGGTGC 
 Cloning R CCCGAATTCTTAATGATGATGATGAT 
 qPCR F ATCAAAACAGACTGGCCATGCTAAT 
 qPCR R AAATTATCACACCAGCGAATGTAGC 
Eta2 Cloning F CATATGTCATTGACACAACTAGG 
Eta2-His Cloning R TTAATGATGATGATGATGATGTATAACCTGTTTCA 
mbact-Eta2 Cloning F TCCAGTTTAGCCATGTCATTGACACAACTAGG 
Eta2-mbact Cloning R GAGAAAGTCTGTTTAATGATGATGATGATGAT 
mbact-LAMP-F Cloning F TCCAGTTTAGCCATGGAACTCTCTCACACGGT 
LAMP-mbact-R Cloning R GAGAAAGTCTGTTTAGATGGTCTGGTATCCAG 
Eta2-LAMP(lum)-R Cloning R GATGGGGATGAGCATATGATGATGATGATG 
LAMP(lum)-pCI-F Cloning F ATGCTCATCCCCATCATCGT 
LAMP(sig)-eta2-F Cloning F GGTTGTATTCAGGCTATGTCATTGACACAA 
pCI-LAMP(sig)-R Cloning R AGCCTGAATACAACCTAGCC 
*Restriction enzyme sites (NdeI and EcoRI) are underlined at the start of the sequence. 
**Between parentheses appear the position of the gene which nucleotides are added in order to 
hybridize at the ends of each domain.  
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Figure 1. Pairwise alignment of LAMP-1 of Japanese flounder (Jf) and Striped beakfish (Sb). 
Cytoplasmic and transmembrane domains show high identity among LAMP-1 molecules. The 
cysteine residues are also conserved. 
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Figure 2. Schematic representation of the expression plasmids used for Eta2 vaccination 
experiments. a) pCEta2, pCIneo harboring Eta2 gene. b) pCLAMP-Eta2, pCIneo harboring the 
chimeric antigen. c) pCmbacEta2, pCIneo harboring Eta2 gene with medaka beta actin 
promoter (mbac). d) pCmbacLAMP-Eta2, pCIneo harboring the chimeric antigen with mbac. 
SP, signal peptide domain; LumD, luminal domain; T, Transmembrane domain; C, 
Cytoplasmic domain. 
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Figure 3. Survival rate of striped beakfish challenged with low dose (mean copy number=1.75 
x103) of RSIV after 30 days of DNA vaccination.  
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Figure 4. Survival rate of striped beakfish challenged with high dose (mean copy number=1.83 
x104) of RSIV after 30 days of DNA vaccination. 
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Figure 5. Survival rate of Japanese flounder challenged with E. tarda after 15 days of DNA 
vaccination. 
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Chapter 5 
 
 
 
 
General conclusion 
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Vaccination is a prophylactic method to induce immunity against specific pathogens and 
protect the animals from disease. Antigens coded in DNA vaccines have shown promising 
result to induce immunity, however for some pathogens the results need to be improved. Thus, 
genetic bioengineering of DNA vaccines can be an alternative to increase the efficacy of the 
vaccines. The use of sorting signals from intracellular molecules to construct chimeric antigens 
may allow to drive the movement of the antigen inside the cell and to modify the immune 
response, in order to increase the immunogenicity and render more protection in the vaccine.  
 
In my study, I hypothesized that the use of the sorting signal from Japanese flounder 
LAMP-1 can increase the immunogenicity of the DNA vaccine using RSIV MCP as antigen. 
For this, JfLAMP-1 was characterized and a chimeric DNA vaccine was constructed and tested. 
 
Thus, JfLAMP-1 gene was cloned and characterized, showing a constitutive expression in 
tissues and upregulation on FKC stimulation with E. tarda. In poly I:C stimulation there was 
no changes in the expression, what make hypothesize a role of JfLAMP-1 mainly in the 
antibacterial immunity. At protein level, JfLAMP-1 appears distributed in granules from 
different sizes group close to the nucleus. 
 
Then, JfLAMP-1 chimeric vaccines were constructed and their efficacy to induce antibody 
immune response and to protect a RSIV-susceptible fish species was probed. LAMP-1 and 
RSIV MCP chimeric antigen in a DNA vaccine showed to induce higher titers of antibodies 
against RSIV MCP in Japanese flounder compared with the conventional DNA vaccine. 
Furthermore, striped beakfish vaccinated with the chimeric vaccine and then challenged with 
RSIV, showed higher survival rates than the individuals vaccinated with the conventional DNA 
vaccine. These findings highlight the potential improvement of the immunogenicity of the 
antigens by using chimeric DNA vaccines.  
 
In conclusion, chimeric antigens coded in DNA vaccines using sorting signals from 
specific molecules can be candidates to enhance the immune response against pathogens, e.g. 
by modulation of the traffic of antigen. 
